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 Abstract                               
The matrilins are non-collagenous extracellular matrix proteins that form a subbranch of 
the superfamily of proteins containing VWA domains. Four matrilins are present in 
mammals, matrilin-1, -2, -3 and –4. The matrilins contain one or two VWA domains 
which are connected by a varying number of EGF-like domains, followed by a 
C-terminal α-helical coiled-coil domain. Matrilins serve as adaptors in the assembly of 
supramolecular structures in the extracellular matrix, but it is not known if this role is 
static or dynamic in nature. The in vivo functions of matrilins remain unclear and need 
to be elucidated in detail, in particular to understand the role of matrilins in inherited 
disease.  
Mutations in the gene encoding human matrilin-3 lead to autosomal dominant skeletal 
disorders, such as multiple epiphyseal dysplasia (MED), which is characterized by short 
stature and early onset osteoarthritis, and bilateral hereditary microepiphyseal dysplasia, 
a variant form of MED characterized by pain in the hip and knee joints. In addition, a 
mutation in the first EGF-like domain of matrilin-3 has been linked to hand 
osteoarthritis in the Icelandic population.  
Matrilin-3 null mice and matrilin-1/-3 double deficient mice were characterized. 
Homozygous matrilin-3 mutant mice appear normal, are fertile, and show no obvious 
skeletal malformations. Histological and ultrastructural analyses reveal an endochondral 
bone formation indistinguishable from that of wildtype animals. Northern blot, 
immunohistochemical, and biochemical analyses showed no compensatory upregulation 
of any other member of the matrilin family. In matrilin-1/-3 double null mice, 
biochemical analyses revealed a molecular phenotype in which the amount of matrilin-4 
protein is increased and the band patterns of matrilin-3 and -4 are altered. The 
upregulation of matrilin-4 is likely to represent a compensatory mechanism. Altogether, 
the findings suggest functional redundancy among matrilins in mammals and 
demonstrate that the phenotypes of MED-like disorders are not caused by the absence of 
matrilin-3, but are likely to be due to dominant negative effects of the mutant proteins. 
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 The zebrafish is a well established model organism for the study of vertebrate 
development. The matrilins are present in neither Drosophila nor in C. elegans and the 
zebrafish is therefore among the simplest organisms which express matrilins. Highly 
conserved orthologues, matrilin-1, -3a, -3b and –4, are present in zebrafish, while the 
matrilin-2 gene is missing. The temporal and spatial expression of zebrafish matrilins 
was characterized. Zebrafish matrilin-1 was found not only in skeletal tissue but also in 
notochord and intestine. Matrilin-3a expression is restricted to skeletal tissues, while the 
expression pattern of matrilin-3b has not yet been elucidated due to the lack of a 
specific antibody. Nevertheless, RT-PCR analysis reveals that matrilin-3b is expressed 
at 24 hpf and, interestingly, splice variants of matrilin-3b containing a proline- and 
serine/threonine-rich domain are found only in embryos but not in adult fish, indicating 
that this new domain probably has an important function during zebrafish development. 
Similar to in mammals, matrilin-4 is the earliest and most widely expressed matrilin in 
zebrafish. Matrilin-4 is strongly expressed already at 24 hpf and is present in the 
skeletal tissues, soft connective tissues and nervous tissues.  
Morpholino antisense oligonucleotides were used to knockdown matrilins expressed in 
zebrafish. Malformations were seen at all the doses used and the phenotypes matched to 
the tissue distribution of the respective matrilin. Injection of matrilin-1 or matrilin-4 
morpholinos give curled body shape, smaller eyes or a truncated body axis depending 
on dosage. The matrilin-3a knockdown embryos showed a serious skeletal phenotype.  
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 Zusammenfassung                 
Die Matriline gehören zu den nicht-kollagenen Proteinen der extrazellulären Matrix, die 
einen Zweig der von Willebrandfaktor A Domänen (VWA) enthaltenden Proteinfamilie 
bilden. Bei Säugetieren gibt es insgesamt vier Matriline, Matrilin-1, -2, -3 und –4. Die  
Matriline enthalten ein oder zwei VWA Domänen, die durch eine unterschiedliche An- 
zahl von epidermalem Wachstumsfaktor ähnlichen Domänen (EGF) verbunden sind, ge- 
folgt von einer C-terminalen α-helikalen Coiled-Coil Domäne. Die Matriline dienen als 
Adaptorproteine bei der Verbindung von supramolekularen Strukturen in der extra- 
zellulären Matrix, es ist aber noch unbekannt, ob die Matriline dabei eine statische oder 
dynamische Rolle spielen. Die genauen in vivo Funktionen der Matriline verbleiben un- 
klar und müssen noch aufgeklärt werden, insbesondere die Rolle, die die Matriline bei 
der Entstehung von bestimmten Erbkrankheiten spielen. 
Mutationen im menschlichen Matrilin-3 Gen führen zu autosomal dominanten Erb- 
krankheiten des Skelettsystems, wie z. B. der multiplen epiphysären Dysplasie (MED), 
die sich durch eine geringe Körpergröße und eine frühzeitig einsetzende Arthrose aus- 
zeichnen oder der bilateralen erblichen mikroepiphysären Dysplasie, einer Variante der 
MED, die durch Schmerzen in Hüft- und Kniegelenken charakterisiert ist. Außerdem 
wurde in der isländischen Bevölkerung eine Mutation in der ersten EGF Domäne von 
Matrilin-3 mit dem Vorkommen von Handarthrose in Verbindung gebracht. 
Matrilin-3 defiziente und Matrilin-1/-3 doppeldefiziente Mäuse wurden untersucht. Die 
homozygoten, mutierten Matrilin-3 Mäuse sehen normal aus, sind fruchtbar und haben 
keinen offensichtlichen skeletalen Phänotyp. Histologische und ultrastrukturelle Unter- 
suchungen zeigten eine endochondrale Knochenentwicklung, die sich von der vom 
Wildtyp nicht unterschied. Northernblot, Immunhistochemie und biochemische Analy- 
sen ergaben keine Hinweise auf eine Hochregulation der anderen Matriline, die das Feh- 
len von Matrilin-3 hätten kompensieren können. Bei der biochemischen Analyse der 
Matrilin-1/-3 doppeldefizienten Mäuse dagegen wurde ein molekularer Phänotyp ent- 
deckt, in dem die Menge an Matrilin-4 erhöht war und sich das Bandenmuster von Ma- 
trilin-3 und –4 verändert hatte. Die Hochregulation von Matrilin-4 beruht wahrschein- 
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 lich auf einem Kompensationsmechanismus. Insgesamt deuten die Ergebnisse auf eine 
funktionelle Redundanz der Matriline bei Säugetieren hin. Die Phänotypen der skeleta- 
len Erkrankungen sind wahrscheinlich nicht durch das Fehlen von Matrilin-3 in der Ma- 
trix, sondern eher durch einen dominant negativen Effekt der mutierten Proteine zu er- 
klären. 
Der Zebrafish ist ein gut eingeführter Modellorganismus bei der Untersuchung der 
Entwicklung von Wirbeltieren. Da die Matriline weder in Drosophila noch in C. elegans 
vorkommen, gehört der Zebrafisch zu den einfachsten Lebewesen, die Matriline 
exprimieren. Im Zebrafisch gibt es hoch konservierte orthologe Gene, die für Matrilin-1, 
-3a, 3b und –4 kodieren, während ein Matrilin-2 Gen fehlt. Die zeitliche und räumliche 
Expression von Matrilinen im Zebrafisch wurde untersucht. Zebrafisch Matrilin-1 
konnte nicht nur in skeletalen Geweben, sondern auch im Notochord und Dünndarm 
nachgewiesen werden. Die Matrilin-3a Expression beschränkt sich auf skeletale 
Gewebe, während die Matrilin-3b Expression nicht untersucht werden konnte, da ein 
geeigneter Antikörper nicht zur Verfügung stand. Dennoch konnte mit Hilfe von 
RT-PCR bereits nachgewiesen werden, dass Matrilin-3b bereits 24 Stunden nach der 
Befruchtung exprimiert wird. Interessanterweise gibt es Spleißvarianten von Matrilin-3b, 
die eine an Prolin und Serin/Threonin reiche Domäne enthalten, welche nur in Embryos, 
aber nicht in erwachsenen Tieren vorkommt, was darauf hinweist, dass die Domäne 
möglicherweise eine Rolle während der Zebrafischentwicklung spielt. Wie bei 
Säugetieren ist Matrilin-4 beim Zebrafisch das am frühesten und breitesten exprimierte 
Matrilin. Matrilin-4 ist bereits 24 Stunden nach der Befruchtung stark exprimiert und 
kommt in skeletalen Geweben, weichen Bindegeweben und in Nervengeweben vor. 
Morpholino Gegenstrangoligonukleotide wurden eingesetzt, um die Expression der Ma- 
triline im Zebrafisch zeitweilig zu unterbinden. Fehlbildungen wurden bei allen ange- 
wandten Dosierungen bobachtet und die Phänotypen passen zu der Gewebeverteilung 
der entsprechenden Matriline. Abhängig von der Dosis ergaben die Injektionen von Ma- 
trilin-1 bzw. Matrilin-4 spezifischen Morpholinos Tiere mit verdrehtem Körper, klei- 
neren Augen oder gar einer verkürzten Körperachse. Die mit einem Matrilin-3a spe- 
zifischen Morpholino behandelten Tiere zeigten einen schweren skeletalen Phänotyp. 
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 1. Introduction                         
1.1. Extracellular matrix proteins 
The extracellular matrix (ECM) is a complex structural entity surrounding and 
supporting cells within tissues. The ECM has received considerable attention due to its 
importance in cell-cell interactions, signalling, wound repair, cell adhesion and tissue 
function. 
The major constituents of the ECM are proteoglycans and collagens, which form a 
tissue-specific network providing the tensile strength and resilience required. A number 
of non-collagenous proteins are also found in the ECM and serve to regulate matrix 
assembly and cell adhesion. 
1.1.1. Proteoglycans 
Proteoglycans are complex macromolecules consisting of a central protein core to 
which a variable number of glycosaminoglycan (GAG) chains are covalently attached. 
Glycosaminoglycans are long, unbranched polyanionic carbohydrate chains consisting 
of repeating disaccharide units. There are four main classes of glycosaminoglycans: 
hyaluronic acid, the chondroitin sulphates (chondroitin 4-sulphate, chondroitin 
6-sulphate, dermatan sulphate), keratan sulphate and the heparin-heparan sulphate class. 
As the glycosaminoglycans carry a large number of sulphate and carboxyl groups, the 
proteoglycans have a high negative net charge, which in turn results in an extended 
conformation due to electrostatic repulsion. Proteoglycans contribute about a third of 
the dry mass of a hyaline cartilage. At this high concentration, they are presumably kept 
in a compressed state by physical entrapment in the network of collagen fibers. The 
electrostatic repulsion between the fixed charged groups will be strong and any further 
compression will be resisted. Therefore, the proteoglycans contribute compressive 
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 stiffness and elasticity to the cartilage. 
Aggrecan is the most abundant proteoglycan in articular cartilage (Doege et al., 1994). 
The protein core is about 230 kDa in size (Watanabe and Yamada, 2002) and is heavily 
substituted with GAG chains. Cartilage matrix deficiency (cmd) in mice (Rittenhouse et 
al., 1978) is a natural functional knockout of the aggrecan gene, in which 7 bp in exon 5 
were deleted resulting in severely truncated molecules (Watanabe et al., 1994). The 
homozygotes (cmd/cmd) are characterized by dwarfism, short limbs, a short trunk, tail 
and snout, as well as a protruding tongue and cleft palate and mice die shortly after birth 
due to respiratory failure (Rittenhouse et al., 1978; Watanabe and Yamada, 2002). Even 
though heterozygous mice appear normal at birth, dwarfism and age-associated spinal 
degeneration are observed while aging (Watanabe et al., 1997), indicating that aggrecan 
plays an important role in cartilage development and maintenance. 
One subgroup of proteoglycans are the small leucine-rich proteoglycans (SLRPs) that 
share a multiple leucine-rich repeat (LRR) structural motif flanked by cysteine residues. 
The LRR domain is composed of ~10 repeats of 24 amino acid residues each, 
preferentially containing asparagin (N) and leucine (L) in conserved positions 
(LX2LXLX2NX(L/I)) (Iozzo, 1999). This motif is involved in many molecular 
recognition processes including cell adhesion, signal transduction, DNA repair and 
RNA processing (Kobe and Deisenhofer, 1994). SLRPs often interact with collagen, 
modifying the deposition and arrangement of collagen fibers in the extracellular matrix, 
but also with cells and with soluble growth factors (Ameye and Young, 2002). The 
interaction of SLRPs with cells and with growth factors like TGF-β may affect the cell 
proliferation in addition to modifying the extracellular environment (Ameye and Young, 
2002). 
The SLRP family is rapidly growing and more than 13 members are known including 
decorin, biglycan, asporin, fibromodulin, lumican, PRELP, keratocan, osteoadherin 
epiphican, mimican, opticin, chondroadherin and myctalopin (Ameye and Young, 
2002). 
Decorin is expressed throughout the body, stabilizes collagen fibrils and plays a 
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 significant role in tissue development and assembly, as well as being involved in direct 
and indirect signaling (Reed and Iozzo, 2002). Mice harboring a targeted disruption of 
the decorin gene are viable but have fragile skin with markedly reduced tensile strength 
and irregular collagen fibril shape (Danielson et al., 1997; Reed and Iozzo, 2002).  
Biglycan consists of a 45-kDa core protein made up almost entirely of leucine-rich 
repeats and is widely distributed in the extracellular matrices of bone and specialized, 
non-skeletal connective tissues. It was shown that biglycan-deficient mice develop 
age-related osteoporosis due to defects in bone marrow stromal cells (Chen et al., 2002).  
Both decorin and biglycan bind to VWA domains in the N-terminal region of collagen 
VI and matrilins are in turn bound to these small leucine-rich proteoglycans (Wiberg et 
al., 2003). 
1.1.2. Collagens 
Collagens are the major proteins of the extracellular matrix, constituting 30% of the 
total protein mass. They play a dominant role in maintaining structures of various 
tissues and have been proven to have functions in cell adhesion, chemotaxis, migration 
and dynamic interplay between cells. In addition, collagens regulate tissue remodelling 
during growth, differentiation, morphogenesis and wound healing (Myllyharju and 
Kivirikko, 2004). 
The primary feature of a typical collagen molecule is its long, stiff, triple-stranded 
helical structure, in which three collagen polypeptide α chains are wound around one 
another in a rope-like superhelix. An α chain is composed of a series of triplet Gly-X-Y 
sequences, in which X is commonly proline and Y often hydroxyproline. Therefore, 
collagens are extremely rich in proline and glycine and both amino acids are important 
in the formation of the triple-stranded helix. Proline stabilizes the helical conformation 
in each α chain because of its ring structure, while glycine is regularly spaced at every 
third residue throughout the central region of the α chain. The hydroxyl groups of 
hydroxyproline and hydroxylysine are thought to form interchain hydrogen bonds thus 
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 helping to stabilize the triple helix. 
Up to date, 28 members of the collagen family have been found (R. Wagener, personal 
communication, Myllyharju and Kivirikko, 2004). According to their assemblies, 
collagens can be divided into the following subgroups (Fig. 1-1): fibril-forming (type I, 
II, III, V, XI, XXIV and XXVII), fibril-associated collagens with interrupted triple 
helices (FACIT) (types IX, XII, XIV, XVI, XIX, XX, XXI, XXII and XXVI), 
hexagonal network forming (types VIII and X), beaded filament-forming (type VI), 
anchoring fibril-forming (type VII), collagens with transmembrane domains (types XIII, 
XVII, XXIII and XXV), nonfibril-forming (type IV), and multiplexin collagens (type 
XV and XVIII) (Myllyharju and Kivirikko, 2004).  
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Fig. 1-1 Members of the collagen superfamily and their known supramolecular assemblies. The figure is 
from (Myllyharju and Kivirikko, 2004). 
 
Among the collagens, collagen type II is cartilage-specific and the predominant 
collagen in cartilage, representing about 90% of the collagen content. It forms a firm 
network that provides tensile strength to the tissue. The fibres also contain type XI 
collagen which is a minor, cartilage-specific collagen representing only a few percent of 
the collagen content. Collagen type IX is associated with the collagen II/XI fibrils and 
has a positively charged domain protruding out from the fibrils that has been suggested 
to interact with proteoglycans. Collagen II/IX fibres form a fine network in the 
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 superficial layer of adult articular cartilage. Collagen type X is mainly restricted to 
hypertrophic cartilage, but has also been shown to be present in the superficially layer 
of articular cartilage (Rucklidge et al., 1996). It has been suggested to have a role in 
endochondral ossification. 
Collagens are known to mediate cell adhesion via integrin receptors. Previous studies 
have indicated the presence of a number of integrin recognition sites in collagens 
(Morton et al., 1994; Staatz et al., 1991). In addition, discoidin domain receptors (DDR), 
a subfamily of receptor tyrosine kinases, also act as receptors for collagens (Vogel et al., 
1997) and the collagen binding sites in DDR2 have been identified (Leitinger, 2003). 
The activation of DDRs mediates cell proliferation, migration and motility. Moreover, it 
was demonstrated that DDRs influence the expression and activity of 
metalloproteinases (Leitinger et al., 2004).  
A great many mutations in collagens have been identified and shown cause diseases 
including osteogenesis imperfecta, many chondrodysplasias, several subtypes of the 
Ehlers-Danlos syndrome, Alport syndrome, Bethlem myopathy, certain subtypes of 
epidermolysis bullosa, Knobloch syndrome and also some cases of osteoporosis, arterial 
aneurysms, osteoarthrosis, and intervertebral disc degeneration (Myllyharju and 
Kivirikko, 2001). 
1.1.3. Non-collagenous proteins 
In addition to collagens and proteoglycans, many non-collagenous proteins are present 
in the ECM. However, in contrast to collagens and proteoglycans, which have been 
studied in detail since many years, the functions of many of the non-collagenous 
proteins are rather unclear.  
Non-collagenous proteins typically contain multiple domains, each harbouring specific 
binding sites for other matrix macromolecules and for cell surface receptors. The first 
well characterized example was fibronectin, a large glycoprotein found both in blood 
plasma and in the extracellular matrix (Hynes and Yamada, 1982). Fibronectin was 
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 shown to have multiple functions, affecting cellular adhesion, cell migration, cellular 
morphology and spreading, cytoskeletal organization, oncogenic transformation, 
phagocytosis, embryonic differentiation and wound healing (Hynes and Yamada, 1982). 
Fibronectin null mutant mice die early in embryogenesis because their endothelial cells 
fail to form proper blood vessels (George et al., 1993). 
In addition to fibronectin, other proteins like osteonectin, tetranectin, tenascins, 
thrombospondins, laminins and matrilins also belong to the non-collagenous proteins.  
The matrilins are widespread, but except for some information on their assembly with 
collagens and proteoglycans, their overall contribution to tissue function is not known. 
1.2. Matrilins 
The matrilins are a family of non-collagenous extracellular matrix proteins that form a 
subbranch of the superfamily of proteins containing VWA domains (for review, see 
(Whittaker and Hynes, 2002)).  
The matrilin family consists of four members with a closely similar domain structure 
(Fig. 1-2). Two VWA domains are connected by a varying number of EGF-like domains. 
These are followed by a C-terminal α-helical coiled-coil domain, which allows the 
oligomerization of the single subunits in a bouquet-like fashion. Only matrilin-3 lacks 
the second VWA domain and here the EGF-like domains are directly connected to the 
coiled-coil domain. In addition, matrilin-2 and -3 contain a stretch of amino acid 
residues at the N-terminus with a high frequency of positively charged side chains. 
Uniquely, matrilin-2 contains a module between the second VWA domain and the 
oligomerization domain that has no homology to any other known protein sequence.  
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Fig. 1-2 Domain structure of mouse matrilins (modified from Wagener et al., 2005).  
 
The matrilins are differentially expressed. Matrilin-1 and –3 are mainly present in 
skeletal tissues (Aszodi et al., 1996; Klatt et al., 2000), whereas matrilin-2 and –4 (Klatt 
et al., 2001; Piecha et al., 1999) are more widely distributed. It is thought that matrilins 
have an adapter function in the extracellular matrix, connecting macromolecular 
networks (Hauser et al., 1996). This role for matrilins was confirmed by recent results 
showing that matrilins-1, -3 and –4 are associated with collagen VI microfibrils 
extracted from rat chondrosarcoma tissue. The matrilins are here bound to the small 
leucine-rich repeat proteins biglycan and decorin, which in turn interact with the 
N-terminal globular domains of the collagen VI molecules (Wiberg et al., 2003). 
1.2.1. VWA domains 
The VWA domains of matrilins consist of about 200 amino acid residues in a classical 
Rossman fold with a central β-sheet surrounded by α-helices. A MIDAS (metal ion 
dependent adhesion site) motif (DXSXSXnTXnD), which may be involved in ligand 
binding, is perfectly conserved in nearly all matrilin VWA domains. The VWA domains 
of matrilins represent an own subgroup of the VWA domains of extracellular matrix 
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 proteins (http://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml) (Marchler-Bauer et al., 
2005). All matrilin VWA domains have higher identity to the members of the subgroup 
than to any other VWA domain, indicating that they originate from a common ancestor 
VWA domain (Deak et al., 1999). Phylogenetic studies assigned the first and the second 
VWA domains into two different groups, of which each splits into a matrilin-1/3 and a 
matrilin-2/4 subbranch (Deak et al., 1999). Among other VWA domain family members, 
the VWA domains of different collagens, vitrin, α1 integrin, WARP and AMACO have 
the highest identity (approx. 30%). It is probable that the VWA domains are the 
principal interaction modules of matrilins, since matrilin-1 and -3 splice variants that 
lack all EGF domains exist in zebrafish (Ko et al., 2005). 
VWA domains are found not only in the matrilins, but also in a large number of other 
extracellular proteins (for review see (Whittaker and Hynes, 2002)) such as von 
Willebrand factor, collagens type VI, VII, XII, XIV, XXI and XXII, complement 
factors B and C2, the H2 and H3 subunits of the inter- α-trypsin inhibitor, the α and 
β-chains of integrins and putative transmembrane proteins of lower eukaryotes 
(Whittaker and Hynes, 2002). Recently, also intracellular proteins like copines were 
identified as members of the family (Tomsig and Creutz, 2002; Whittaker and Hynes, 
2002).  
1.2.2. EGF-like domains 
Except for some splice variants in zebrafish which lack EGF-like domains, all other 
matrilins contain at least one such domain, the highest number being in a splice variant 
of zebrafish matrilin-4 where 12 EGF domains are present (Ko et al., 2005). EGF 
domains contain 40-50 amino acid residues, including six conserved disulphide bonds. 
The structure shows a two stranded β-sheet and often EGF domains are present in 
multiple copies (Rao et al., 1995). The function of the EGF domains of matrilins is still 
not clear. A comparison of the matrilin EGF domains with the key residues of the 
calcium-binding motifs in calcium binding EGF domains (Handford et al., 1991; Rao et 
al., 1995) showed no match with the consensus sequence. Neither was a non-canonical 
calcium binding site (Malby et al., 2001) detected in matrilin EGF domains. 
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 Moreover, even though matrilin EGF domains show an overall structural similarity to 
epidermal growth factor, there is no evidence that they retain growth factor activity. It is 
more likely that they serve as spacers between VWA domains, which in many other 
proteins show ligand binding activities. 
Database searches show that EGF domains of scube proteins, fibulins and fibrillins have 
the highest homologies to matrilin EGF domains (Wagener et al., 2005). 
1.2.3. Coiled-coil domains 
The matrilins contain a C-terminal α-helical coiled-coil domain that allows 
oligomerization of the subunits in a bouquet-like fashion. Coiled-coil domains are 
characterised by heptad repeats (a-g) of amino acid residues that typically have 
non-polar amino acids at position a and d. The coiled-coil domains of matrilins contain 
4.5 heptad repeats, showing the least perfect match with the consensus sequence for 
matrilin-3. Nevertheless, by SDS-PAGE and electron microscopy of full-length proteins, 
it has been shown that matrilin-1 and -4 form homo-trimers (Hauser and Paulsson, 1994; 
Klatt et al., 2001), whereas matrilin-2 and -3 form homo-tetramers (Klatt et al., 2000; 
Piecha et al., 1999). The oligomerization was also studied by using recombinantly 
expressed coiled-coil domains (Frank et al., 2002). The analysis of oligomerization in 
mixtures of isolated coiled-coil domains showed a broad range of interactions and the 
only hetero-oligomers not found were those containing matrilin-2 and -3 or matrilin-3 
and -4 (Frank et al., 2002). In contrast, here the coiled-coil domain of matrilin-2 formed 
only trimers. It could well be that the oligomerization is influenced by the unique 
domain adjacent to the coiled-coil domain of matrilin-2. Hetero-oligomeric forms of 
matrilin-1 and -3 have been isolated from fetal human and calf cartilage (Klatt et al., 
2000; Kleemann-Fischer et al., 2001; Wu and Eyre, 1998). There is no conclusive 
evidence for natural occurrence of other hetero-oligomers, but a SDS-PAGE band from 
an extract of newborn mouse epiphyseal cartilage was shown by peptide mass 
fingerprinting to contain both matrilin-1 and matrilin-4 (G. Sengle, unpublished results).  
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 1.2.4. Matrilin-1 
Matrilin-1, which was first purified from bovine cartilage, is the prototype member of 
the family and was originally called "cartilage matrix protein" or CMP (Paulsson and 
Heinegard, 1979). It is an abundant protein in many forms of cartilage. The single 
subunit has a molecular weight of 52,000 Da and contains 3.9% carbohydrate, probably 
in the form of N-linked glycans (Paulsson and Heinegard, 1981). In electron 
microscopy matrilin-1 shows the typical bouquet-like structure where the single VWA 
domains of the subunits are not resolved, indicating an interaction between VWA1 and 
VWA2 (Hauser and Paulsson, 1994) (Fig. 1-3). The solution structure of the 
oligomerization domain of matrilin-1 has been determined by heteronuclear NMR 
spectroscopy. As predicted, the domain folds into a parallel, disulfide-linked, 
three-stranded, α-helical coiled coil, spanning five heptad repeats in the amino acid 
sequence (Dames et al., 1998). 
 
 
Fig. 1-3 Oligomerization of matrilin-1 visualized by electron microscopy. The figure is modified from 
(Hauser and Paulsson, 1994). In the schematic drawing the VWA domains are in dark blue, the EGF-like 
domains are in green and the coiled-coil domain is in light blue. 
 
In the mouse, matrilin-1 can be detected by antibody labeling in myocardium at 9.5 
days p.c. (Segat et al., 2000). This expression is however transient and of unknown 
physiological significance. More lasting expression is seen for both matrilin-1 and –3 in 
the condensing mesenchyme at day 12.5 p.c.. Matrilin-1 expression is restricted to 
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 certain types of cartilage. In the mouse tibial growth plate, matrilin-1 is abundant in 
resting, proliferating and hypertrophic cartilage (Klatt et al., 2002), but it is not present 
in articular and intervertebral disc cartilages (Aszodi et al., 1996; Aszodi et al., 1994). 
Moreover, in situ hybridization analysis of matrilin-1 mRNA showed a downregulation 
concomitant with the progress of hypertrophy at later stages of chondrogenesis (Aszodi 
et al., 1996). 
Matrilin-1 is abundantly expressed in tracheal, nasal septum, auricular, and epiphyseal 
cartilages (Paulsson and Heinegard, 1982), and continued expression of matrilin-1 is 
seen in tissues that remain cartilaginous during the whole lifespan, e.g. in costal 
cartilage and in the nasal septum (Klatt et al., 2002). 
The genetic basis for matrilin-1 gene expression has been studied in some detail in the 
chicken system. A minimal promoter has been defined that functions both in 
chondrocytes and fibroblasts (Goetinck et al., 1990). An enhancer exerts a 
chondrocyte-specific stimulation on the promoter activity and a silencer inhibits activity 
both in chondrocytes and fibroblasts. The enhancer is independent of the developmental 
stage of the chondrocytes, while promoter upstream control regions appear to restrict 
the promoter activity to certain chondrocyte developmental stages (Muratoglu et al., 
1995). Transgenic experiments with the chicken matrilin-1 promoter in mouse have 
indicated that the tissue specific control elements are divided between the promoter 
upstream and intronic regions in a manner similar to that of the Col11a2 gene (Karcagi 
et al., 2004). 
Matrilin-1 was first recognized as a protein tightly bound to aggrecan and which 
copurified with aggrecan in a variety of separation methods (Paulsson and Heinegard, 
1979). The bound matrilin-1 molecules with time become covalently crosslinked to the 
aggrecan core protein, with at least some of the crosslinks not being sensitive to 
reduction (Hauser et al., 1996). In addition, an interaction was found between matrilin-1 
and cartilage collagen fibrils (Winterbottom et al., 1992) and between matrilins and 
other non-collagenous molecules, in particular COMP and decorin (Mann et al., 2004). 
Furthermore, matrilin-1 has the ability to enhance the adhesion of chondrocytes via 
integrin α1β1 (Makihira et al., 1999). However, two different strains of mice lacking 
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 matrilin-1 show normal skeletal development (Aszodi et al., 1999; Huang et al., 1999). 
Nevertheless, in one of the two strains the mice have alterations in type II collagen 
fibrillogenesis and fibril organization (Huang et al., 1999). 
Matrilin-1 is a potential autoantigen able to trigger the tissue-specific immune response, 
as seen both in patients and in animals, resulting in relapsing polychondritis and related 
autoimmune diseases (Buckner et al., 2000; Hansson et al., 1999; Hansson et al., 2001; 
Hansson and Holmdahl, 2002). It has also been reported that the expression of 
matrilin-1 is enhanced in knee osteoarthritic cartilage and in knee or hip rheumatoid 
arthritic cartilage (Okimura et al., 1997). In addition, elevated serum levels of matrilin-1 
were detected in patients with active rheumatoid arthritis (Saxne and Heinegard, 1989). 
Matrilin-1 also showed an increased expression in specimens from arthritic condylar 
cartilage of temporomandibular joints (Ohno et al., 2003). 
1.2.5. Matrilin-2 
Matrilin-2 is the largest matrilin with a calculated molecular weight of 104,300 Da and 
also carries N-linked glycans (Piecha et al., 1999). A 3.9-kilobase matrilin-2 mRNA was 
detected in a variety of mouse organs, including calvaria, uterus, heart, and brain, as 
well as fibroblast and osteoblast cell lines (Deak et al., 1997). Similar to matrilin-1, in 
electron microscopy the two VWA domains appear to bind to each other causing the 
subunit to form a loop extending from the central coiled-coil (Fig. 1-4). Both 
recombinant matrilin-2 and the protein detected by immunoblot in tissue extracts are 
often degraded and actually seen as a ladder of bands in SDS-PAGE. This is most likely 
due to proteolytic processing. 
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Fig. 1-4 Oligomerization of matrilin-2 visualized by electron microscopy. The figure is modified from 
(Piecha et al., 1999). In the schematic drawing the VWA domains are in dark blue, the EGF-like domains 
are in green, the coiled-coil domain is in light blue and the unique sequence is in gray. 
 
The expression pattern of matrilin-2 is much broader than those of matrilin-1 and -3 and, 
despite being present also in cartilage, matrilin-2 is found mainly in loose connective 
tissue. The first matrilin-2 expression in the mouse embryo is in heart, just like for 
matrilin-1, but matrilin-2 is expressed later, at day 10.5 p.c., and the expression 
continues (Segat et al., 2000). Later in development it is produced by a wide variety of 
connective tissue cells, but also by smooth muscle cells and some epithelia (Piecha et al., 
1999). Matrilin-2 protein is deposited by these cells into their pericellular matrix. In 
some cases it becomes associated with basement membranes, even though it is uncertain 
if it is an integral basement membrane protein. In other cases matrilin-2 is found as a 
component of a filamentous network of unknown overall composition (Piecha et al., 
1999). In general, matrilin-2 has a complementary expression pattern to matrilin-1 and 
-3, even though there is some matrilin-2 present also in cartilage. 
Matrilin-2 null mice have been produced and show no gross abnormalities during 
embryonic or adult development, are fertile, and have a normal lifespan (Mates et al., 
2004). 
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 1.2.6. Matrilin-3 
The matrilin-3 subunit is the simplest in the matrilin family consisting of only one 
VWA domain followed by four EGF-like domains and a C-terminal coiled-coil domain 
(Wagener et al., 1997). By MALDI-TOF mass spectrometry the molecular weight was 
determined to 49,300 Da. This value closely matches the calculated mass, indicating the 
lack of glycosylation. Due to the absence of the second VWA domain there is no 
self-interaction in the subunits and in electron microscopy the tetrameric matrilin-3 
appeared to have more extended and flexible arms (Fig. 1-5). 
 
Fig. 1-5 Oligomerization of matrilin-3 visualized by electron microscopy. The figure is modified from 
(Klatt et al., 2000). In the schematic drawing the VWA domains are in dark blue, the EGF-like domains 
are in green and the coiled-coil domain is in light blue. 
 
Matrilin-3 can form homotetramers via the coiled-coil domain (Klatt et al., 2000), and, 
in addition, mixed trimers and tetramers of matrilin-3 and matrilin-1 have been 
described for man (Kleemann-Fischer et al., 2001) and calf (Klatt et al., 2000; Wu and 
Eyre, 1998), whereas these heterooligomers could not be identified in mouse (Aszodi et 
al., 1999). 
In mouse, matrilin-3 is expressed in dense connective tissue during growth and 
remodeling and can be detected earliest at day 12.5 p.c. in the cartilage anlagen of the 
developing bones. In newborn mice matrilin-3 is abundant in the developing occipital 
bones and the bones of the nasal cavity, the cartilage primordium of the vertebral 
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 bodies, the ribs and the long bones, as well as in sternum and trachea (Klatt et al., 2000; 
Klatt et al., 2002), while in 6-week-old mice the expression is restricted to the growth 
plates of long bones, sternum and vertebrae (Klatt et al., 2002) and the tracheal 
perichondrium (Klatt et al., 2000). Matrilin-3 is mostly co-localized with matrilin-1, 
except for the most superficial cell layer in the articular cartilage, where only matrilin-3 
can be detected. The matrilin-3 expression gradually ceases after birth while matrilin-1 
remains in cartilages throughout life (Klatt et al., 2002). 
Mutations in matrilin-3 were found to be linked to autosomal dominant forms of 
multiple epiphyseal dysplasia (MED), a relatively mild and clinically variable 
osteochondrodysplasia, primarily characterized by delayed and irregular ossification of 
the epiphyses and early onset osteoarthritis (Chapman et al., 2001). The mutations 
mostly affect residues within the conserved β strands of the single VWA domain of 
matrilin-3 (Jackson et al., 2004; Mabuchi et al., 2004). In bilateral hereditary 
micro-epiphyseal dysplasia (BHMED), which gives a skeletal phenotype similar to but 
still distinct from common MED, a site close to the β-strands of matrilin-3 is affected 
(Mostert et al., 2003). MED is also caused by autosomal dominant mutations in the 
genes encoding COMP (Briggs et al., 1995) and the α1, α2, and α3 chains of type IX 
collagen (COL9A1, COL9A2, and COL9A3) (Czarny-Ratajczak et al., 2001; Muragaki 
et al., 1996; Paassilta et al., 1999) and it is of interest that mutations in the functionally 
related protein matrilin-3 causes similar phenotypes. In addition, in an autosomal 
recessive form of another osteochondrodysplasia, spondylo-epi-metaphyseal dysplasia 
(SEMD), that is associated with vertebral, epiphyseal, and metaphyseal anomalies, 
again the matrilin-3 gene is affected (Borochowitz et al., 2004). The disease is caused 
by a change of a cysteine into a serine in the first EGF domain of matrilin-3, which 
could lead to disturbance in the disulphide bond formation. In a genomic screen of the 
Icelandic population, a mutation in the first EGF domain of matrilin-3 was linked to the 
occurrence of hand osteoarthritis. Slightly more than 2% of patients with hand 
osteoarthritis carry the mutation (Stefansson et al., 2003), but it was also identified in 
unrelated controls (Jackson et al., 2004; Stefansson et al., 2003). In a recent study, the 
influence of those MED, SEMD and hand osteoarthritis mutations on the secretion of 
matrilin-3 was studied (Otten et al., 2005). Whereas matrilin-3 carrying the hand 
osteoarthritis mutation could be secreted by chondrocytes at a similar rate as wildtype 
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 matrilin-3, the matrilin-3 mutants causing MED and SMED, respectively, were retained 
in the endoplasmic reticulum. It is likely that this retention causes a chondrocyte 
dysfunction by which MED and SMED phenotypes could be explained. Similar 
observations were earlier made for COMP mutations leading to MED (for review see 
(Briggs and Chapman, 2002; Posey et al., 2004)). In contrast, the mutant matrilin-3 that 
has been linked to hand osteoarthritis is synthesized, processed, secreted and deposited 
in a way indistinguishable from the wildtype protein, suggesting, at the most, subtle 
effects of this mutation on the structure and function of the protein (Otten et al., 2005). 
1.2.7. Matrilin-4 
Matrilin-4 contains in mouse four EGF domains between the two VWA domains 
(Wagener et al., 1998). The recombinant protein has a molecular weight of 72,900 Da 
indicating 7 % posttranslational modifications (Klatt et al., 2001). Although matrilin-4 
carries two VWA domains, in electron microscopy these show no obvious interaction 
(Fig. 1-6). The images show the three C-terminal VWA domains at the center, 
presumably held together by the coiled-coil domain. The subunits extend from this 
central structure and end in globular domains representing the N-terminal VWA domain. 
The structure of matrilin-4 is reminiscent of that of matrilin-3, except for the latter 
protein forming tetramers. 
 
Fig. 1-6 Oligomerization of matrilin-4 visualized by electron microscopy. The figure is modified from 
(Klatt et al., 2001). In the schematic drawing the VWA domains are in dark blue, the EGF-like domains 
are in green and the coiled-coil domain is in light blue. 
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 Matrilin-4 is the most ubiquitous of all matrilins and appears to be present wherever 
another matrilin is found (Klatt et al., 2001). It can be detected by 
immunohistochemistry in the ectoplacental cone already at day 7.5 p.c. (Klatt et al., 
2001). Affinity-purified antibodies detect a broad expression in dense and loose 
connective tissue, bone, cartilage, central and peripheral nervous system and in 
association with basement membranes. The expression in nervous tissue is more 
pronounced than for other matrilins, and indeed the brain appears to be the most 
abundant tissue source for matrilin-4.  
When matrilin-4 expression was studied in the mouse by northern hybridization, mRNA 
could be detected in lung, sternum, brain, kidney and heart (Wagener et al., 1998). The 
broad tissue distribution is reminiscent of that of matrilin-2, and phylogenetic analyses 
show (Deak et al., 1999) that matrilin-4 and matrilin-2 descend from a common 
ancestor, further indicating a close relationship. 
Matrilin-4 is often degraded and is actually seen as a ladder of bands in SDS-PAGE 
when isolated from tissue or cell culture (Klatt et al., 2001). This processing was studied 
in some detail. Recombinantly expressed matrilin-4 from human embryonic 
kidney-derived 293 (HEK-293) cells is found as a mixture of monomers, dimers and 
trimers (Klatt et al., 2001). Analysis of fragments by MALDI-TOF mass spectrometry 
and Edman degradation showed that the cleavage occurs at a distinct site in the short 
linker region which resides between the C-terminal VWA domain and the coiled-coil 
domain. The processing results in an almost complete subunit being released from the 
major part of the molecule consisting of the coiled coil together with remaining subunits. 
Similar linker regions occur also in the other matrilins, but it is noteworthy that in 
matrilin-1, which is the least sensitive to proteolysis, this linker is the shortest. At least 
for matrilin-4 it has been shown that fragments corresponding to those characterised for 
the recombinant protein occur also in tissue extracts (Klatt et al., 2001). It appears that 
this depolymerization is a physiological process and it may serve the purpose of 
decreasing the avidity of matrilins for their ligands and thereby cause a disassembly of 
supramolecular structures held together by matrilins. 
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 1.3. Model organisms 
Several model organisms, including mouse, xenopus, zebrafish, chicken, Drosophila 
and C. elegans, are widely employed in the search for gene function since each 
organism has its own advantages and disadvantages. Mouse is the animal model most 
often used because it is the species closest to human and therefore the gene function in 
mouse is most likely to mimic that in human. However, the complexity in gene 
regulation and the occurrence of compensation of one gene product for another often 
makes it difficult to elucidate the function of a certain protein. This may account for the 
lack of obvious phenotypes in some knockout mice. Hence, use of different model 
organisms might be required to unveil protein function.  
As matrilins were found only in vertebrates, but not in Drosophila or in C. elegans, the 
zebrafish (Danio rerio), which is a powerful model organism for the study of vertebrate 
development, is the lowest animal in which matrilin function can be studied. The 
embryos develop rapidly, with all organs having been formed by 72 hpf (hours post 
fertilization). The externally developing embryos are optically clear and are produced in 
large numbers, therefore large-scale mutagenesis programs can be monitored by simple 
microscopic observation of the embryos (Haffter et al., 1996). A genome-sequencing 
project will be completed soon and human diseases that resemble mutations in zebrafish 
have been extensively analyzed (Shin and Fishman, 2002).  
1.4. Zebrafish matrilins 
In a screen of the zebrafish databases (NCBI and Ensembl) with sequences of 
mammalian matrilin VWA domains as query, we identified single orthologue genes for 
matrilin-1 and -4 and two orthologue genes for matrilin-3. Part of the work performed in 
my dissertation builds on this identification and both studies were published together 
(Ko et al., 2005).  
In contrast to in mammals, no orthologue of matrilin-2 was found in zebrafish, either by 
RT (reverse-transcriptase) PCR using degenerated primers or by screening the 
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 databases (Ensembl and NCBI); however, two forms of matrilin-3, matrilin-3a and -3b, 
are present. Phylogenetic trees show that the VWA domains of zebrafish are located in 
the same branches as the respective mouse domains, clearly showing that they are 
orthologues (Fig. 1-8). In apparent contrast to zebrafish, pufferfish (Fugu rubripes) 
contains a matrilin-2 gene.  
The identity with the mammalian matrilins is more than 70% for the VWA domains and 
only 28% for the coiled-coil domains of matrilin-3a and -3b. All zebrafish matrilins 
show a greater variety of splice forms than in mammals, with splicing mainly affecting 
the number of EGF-like repeats.  
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Fig. 1-7 Domain structure of zebrafish matrilins. matn, matrilin; P S/T –rich, proline- and 
threonine/serine-rich The figure is modified from (Ko et al., 2005). 
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Fig. 1-8 Phylogenetic analyses of matrilin VWA domains. VWA domain amino acid sequences of 
zebrafish (z), pufferfish (Fugu rubripes) (f) and mouse (m) were aligned with the PILEUP program of the 
GCG package, using the default parameters. The VWA4 domain of human collagen XII α1 (colXII α1) 
was taken as an outgroup. The aligned sequences were used for the construction of a tree by the 
PROTPARS program of the PHYLIP package, version 3.5. Bootstrap support values were obtained with 
100 replicates and are given at the respective nodes when the values are below 70%. The VWA domains 
of pufferfish (Fugu rubripes) were derived from the draft sequence of pufferfish (Fugu rubripes) genome, 
available as pufferfish (Fugu rubripes) assembly release 3. The genomic sequence of the VWA1 domain 
of pufferfish (Fugu rubripes) matrilin-4 is not yet available. matn, matrilin. The figure is from (Ko et al., 
2005). 
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 1.4.1. Matrilin-1 
The mature secreted protein has a calculated Mr of 51,555. It comprises two VWA 
domains that are connected by a single EGF-like domain followed by an α-helical 
coiled-coil oligomerization domain, and therefore completely resembles the mammalian 
matrilin-1 (Fig. 1-7). Furthermore, by RT-PCR an alternatively spliced mRNA that 
lacks the EGF-like domain was also detected (Fig. 1-7). 
1.4.2. Matrilin-3a 
For matrilin-3a alternatively spliced cDNAs occur that contain sequences coding for 
three or four EGF-like domains (Fig. 1-7). In addition, an isoform exists that lacks the 
four EGF-like domains that in mammals connect the VWA domain and the C-terminal 
coiled-coil domain (Fig. 1-7). The longest cDNA encodes a protein of 480 amino acid 
residues with a calculated Mr of 53,006, the shortest protein of 295 amino acid with a 
calculated Mr of 32,811.The stretch of amino acid residues N-terminal to the VWA 
domain is conserved between mammalian matrilin-3 and zebrafish matrilin-3a, but with 
fewer positively charged amino acid residues in zebrafish. 
1.4.3. Matrilin-3b 
In a later screen of the genomic database, a second matrilin-3 gene was identified. 
RT-PCR yielded four alternatively spliced matrilin-3b cDNAs. The longest splice 
variant of matrilin-3b has an open reading frame of 1,437 bp that codes for a protein 
comprising 478 amino acid residues. After cleavage of a predicted signal peptide of 22 
amino acid residues, the mature secreted protein has a calculated Mr of 50,136. The 
VWA domains of matrilin-3a and -3b are 80% identical at the amino acid level. 
Uniquely in a matrilin, a proline- and threonine/serine-rich sequence (Fig. 1-9) precedes 
the N-terminal VWA domain in matrilin-3b, which itself is followed by a single 
EGF-like domain and the C-terminal coiled-coil domain. The long unique N-terminal 
stretch of amino acid residues also contains a cluster of positively charged amino acid 
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 residues (Fig. 1-7) similar to that in matrilin-3a. The matrilin-3b variant that lacks the 
proline- and threonine/serine-rich sequence and the EGF-like domain has the same 
domain structure as the shortest form of matrilin-3a, containing only the N-terminal 
positively charged stretch, a single VWA-domain and the coiled-coil domain. In 
addition, two isoforms exist that lack either the proline- and threonine/serine-rich 
sequence or the EGF-like domain (Fig. 1-7). The NetOGlyc server 
(http://www.cbs.dtu.dk/services/NetOGlyc/) predicted that the proline- and 
threonine/serine-rich sequence contains 33 potential mucin-type N-acetylgalactosamine 
O-glycosylation sites. 
 
Fig. 1-9 Amino acid sequence of the proline- and serine/threonine-rich domain in zebrafish matrilin-3b. 
Predicted mucin-type N-acetylgalactosamine O-glycosylation sites are shaded black.  
1.4.4. Matrilin-4 
As in the mammalian matrilin-4, the two VWA domains are connected by EGF-like 
domains followed by the C-terminal coiled-coil domain (Fig. 1-7). Alternatively spliced 
mRNAs exist with different numbers of EGF-like domains, ranging from four to twelve 
(Fig. 1-7). The longest form has a calculated Mr  of 102,576 and thereby has nearly the 
same Mr as mammalian matrilin-2. 
1.4.5. Sequence analysis 
The identity of zebrafish VWA domains with their mouse counterparts is 71–72% and 
the lengths of the VWA domains are strongly conserved. The matrilin-3 A1 domains 
perfectly fit to the MIDAS (metal ion-dependent adhesion site) motif consensus 
sequence (DXSXSXnTXnD), which is in contrast to human and mouse matrilin-3 
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 where the threonine in the MIDAS motif has been exchanged for a serine residue. 
Phylogenetic analysis did not allow construction of a tree of the zebrafish EGF-like 
domains with reasonable bootstrap values. Nevertheless, the zebrafish matrilin-4 
EGF-like domains 7 and 8 are identical on the protein level and the domains 3, 4, 5, 6, 9, 
10 and 11 are nearly identical, and are probably the products of recent duplication 
events. The identity of the orthologue EGF-like domains is lower than for the VWA 
domains with highest values of 66.7% for the EGF-like domain of zebrafish and mouse 
matrilin-1, 65% for the EGF-like domain 11 of zebrafish matrilin-4 and EGF-like 
domain 3 of mouse matrilin-4 and 55.8% for EGF-like domain 4 of zebrafish 
matrilin-3a and the EGF-like domains 1 and 4 of mouse matrilin-3.  
All zebrafish matrilins contain a coiled-coil α-helix at the C-terminus, as predicted by 
the COILS program (Lupas et al., 1991). As for mouse matrilin-3, the agreement with 
the consensus is the lowest for zebrafish matrilin-3b, whereas matrilin-3a has a higher 
match. The coiled-coil domains of zebrafish and mouse matrilin-1 show an identity of 
67%, whereas it is 48% for matrilin-4 and only 28% for each of matrilin-3a and -3b. 
1.5. Gene silencing methods 
Gene silencing by antisense oligonucleotides is increasingly used to achieve 
loss-of-function or knockdown of genes of interest and forms an attractive alternative to 
knockouts. Several antisense oligonucleotides with modified backbones have over the 
past decade been designed to improve specificity and efficacy (Braasch and Corey, 
2002). However, their ability to provide unambiguous phenotypes has been debated and, 
in some instances, they have proven seriously flawed regarding specificity, cell toxicity, 
efficiency and efficacy (Braasch and Corey, 2002; Summerton and Weller, 1997). The 
discovery of RNAi was a breakthrough and, indeed, more than 3000 publications have 
used RNAi since 2002. In addition to RNAi, morpholino antisense oligonucleotides 
(short: morpholinos) have been in use since 2000 and the two techniques are considered 
as the most powerful antisense approaches.  
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 1.5.1. RNAi 
RNA interference (RNAi) is a gene silencing technique in which exogenous 
double-stranded RNA (dsRNA) that is complimentary to known targeted mRNA is 
introduced into a cell and triggers the degradation of that particular mRNA, thereby 
diminishing or abolishing gene expression (Hannon, 2002). 
The specificity component of the RNAi machinery is small-interference RNA (siRNA). 
dsRNA is cleaved into ~23 bp siRNAs by dicer (Denli and Hannon, 2003), an enzyme 
that belongs to the RNase III family. Then the siRNA-dicer complex recruits additional 
components to form an RNA-Induced Silencing Complex (RISC) in which the unwound 
siRNA base pairs with complementary mRNA, thus guiding the RNAi machinery to the 
target mRNA resulting in the effective cleavage and subsequent degradation of the 
mRNA (Denli and Hannon, 2003; Hammond et al., 2000; Zamore et al., 2000) (Fig. 
1-10).  
The technique has proven effectively in Drosophila (Schwarz et al., 2002) , C. elegans 
(Fire et al., 1998), plants (Hamilton and Baulcombe, 1999) and, recently, in mammalian 
cell culture (Chiu and Rana, 2002). The usefulness of RNAi in animal experiments and 
preclinical drug development remains to be established (Paroo and Corey, 2004). 
Even though RNAi is considered as a powerful technique to elucidate the function of a 
gene in respect of efficiency, efficacy and cost, the real mechanism has been rather 
mysterious with regard to specificity. It has been observed that two classes of siRNA 
(21-22nt and 24-26nt) existing in plants differ not only in size but also in their 
mechanism of gene-silencing (Hamilton et al., 2002). The short siRNA (21-22 nt) is 
correlated directly with mRNA degradation whereas the long siRNA (24-26 nt) is 
involved in systemic silencing and DNA methylation (Denli and Hannon, 2003; 
Hamilton et al., 2002). In addition, micro RNAs (miRNAs) are also found to be 
processed by dicer from 70 nt pre-miRNA into a 22 nt mature form that can regulate 
gene expression either through mRNA degradation or translational repression which 
depends on the degree of the complementation to mRNA sequence (Bartel, 2004; Denli 
and Hannon, 2003). Nevertheless, siRNA and miRNA induced gene silencing through 
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 mRNA degradation pathways are both mediated by the RNA-induced silencing complex 
(RISC) (Bartel, 2004). Therefore, it is difficult to distinguish which component accounts 
for the final gene silencing. The propensity for nonspecific effects is always the main 
concern in the antisense field. The frequent lack of proper and sufficient controls in 
papers describing the use of RNAi has been noticed (Anonymous, 2003).  
 
Fig. 1-10 Present model for the RNAi mRNA degradation pathway. Anti-parallel dicer dimers cleave 
long dsRNAs to form small-interfering RNAs (siRNAs) in an ATP-dependent manner. siRNAs are 
incorporated in the RNA-Induced Silencing Complex (RISC) and ATP-dependent unwinding of siRNAs 
activates RISC. Active RISC is thus guided to degrade the specific target mRNAs. The figure is modified 
from (Denli and Hannon, 2003).  
 
1.5.2. Morpholino antisense oligonucleotides (morpholinos) 
Morpholinos are non-ionic DNA analogs comprised of a nucleic acid base, a 
morpholine ring and a non-ionic phosphorodiamidate intersubunit linkage. (Fig. 1-11)  
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 Morpholinos were first developed for clinical therapeutic applications, where previous 
antisense approaches had proven seriously flawed (Summerton and Weller, 1997). They 
were introduced into developmental biology as a tool to inhibit gene function in 2000 
(Heasman et al., 2000), and since then they have been used by researchers in various 
model organisms, including see urchin (Howard et al., 2001), xenopus (Heasman et al., 
2000), zebrafish (Nasevicius and Ekker, 2000), chicken (Kos et al., 2001) and mouse 
(Coonrod et al., 2001). In addition, a successful and efficient delivery of morpholinos in 
adherent and nonadherent cultured cells has been reported (Morcos, 2001). Moreover, 
an entire issue of the journal “Genesis” (volume 30, issue 3, 2001) was dedicated to 
articles studying gene function in development using the morpholino approach. 
 
 
Fig. 1-11 Structure of DNA and morpholino oligonucleotides. The figure is from (Corey and Abrams, 
2001). 
 
In contrast to traditional antisense oligonucleotide approaches that utilize RNase H 
based degradation of mRNA as a mechanism of action, morpholinos do not recruit 
RNase H and thus the efficacy is achieved through nonclassical antisense approaches 
(Summerton, 1999; Summerton and Weller, 1997). It has been demonstrated that 
morpholinos are not subject to a wide range of nucleases (Summerton and Weller, 1997) 
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 and that morpholinos are not degraded in the organism. As a consequence, there is no 
risk that modified nucleosides or nucleotides resulting from degradation of an antisense 
oligonucleotide might be toxic or might be incorporated into cellular genetic material 
and thereby lead to mutations and/or other undesired biological effects. 
Moreover, the phosphorodiamidate linkage in morpholinos gives an excellent water 
solubility and provides a neutrally charged backbone which is less likely to interact with 
cellular proteins thus reducing the risk for non-specific side effect (Corey and Abrams, 
2001; Ekker, 2000).  
In summary, morpholinos have greater efficacy, specificity, solubility and stability than 
other antisense oligonucleotides (Heasman, 2002). 
Morpholinos can function either through altering pre-mRNA splicing or inhibiting 
translation (Ekker and Larson, 2001). Binding of morpholinos to exon/intron junctions 
will lead to that an entire exon is left out, resulting in the formation of a non-functional 
mRNA (Fig. 1-12) (Ekker and Larson, 2001). These splice-blocking morpholinos have 
the advantage that the efficacy of the knockdown can be easily quantified using RT-PCR 
or standard RNA analysis techniques without the use of antibodies (Draper et al., 2001). 
It was observed that targeting of the splice donor boundaries gives a better knockdown 
than blocking at an splice acceptor site but the reason is unknown. Nevertheless, 
morpholinos targeting splice donor sites have produced pronounced phenotypes in 
zebrafish embryos (Draper et al., 2001; Yan et al., 2002).  
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Fig. 1-12 The use of morpholinos in altering RNA processing. (a) Cartoon of RNA splicing events for an 
arbitrary gene. (b) One example of morpholino induced alterations in RNA splicing, exon skipping. The 
figure is from (Ekker and Larson, 2001). 
 
Fig. 1-13 The use of morpholinos (MO) for translational inhibition. (a) Cartoon of the translation of an 
arbitrary mRNA. The 40S ribosomal subunit scans the leader sequence, identifies the start codon, and 
then recruits the 60S subunit for polypeptide synthesis initiation. (b) Binding of an MO to the 5’ end of 
the gene inhibits the scanning process and translation. (c) Effective target selection for morpholino. The 
figure is from (Ekker and Larson, 2001). 
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 Translational inhibition is the other morpholino targeting strategy. Morpholinos with a 
sequence selected to target the leader sequence or nearby bases can sterically inhibit 
scanning of the mRNA by the 40S ribosomal subunit and subsequently result in 
translational inhibition (Fig. 1-13). Efficacy appears restricted to target sites within the 
leader sequence and sequences surrounding the start codon (Fig. 1-13 C) (Ekker and 
Larson, 2001; Summerton, 1999). Once translation has been initiated, morpholinos are 
not capable of altering the activity of ribosome complex. Binding of morpholinos to 
mRNA does not appear to facilitate or retard mRNA degradation (Nasevicius and Ekker, 
2000). Hence, the efficacy of translational-inhibition morpholinos should be evaluated 
at the protein level instead of the mRNA level.  
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 1.6. The aims of the dissertation 
Despite the increased biochemical information on matrilin interactions, the detailed in 
vivo functions are not known. It is clear that matrilins serve as adaptors in the assembly 
of supramolecular structures in the extracellular matrix, but it is not known if this role is 
static or dynamic in nature. Matrilins therefore need to be studied in genetic models. 
Matrilin-3 deficient mice were generated in collaboration with Dr. A. Aszodi, 
Martinsried, and one aim of this dissertation was to characterize the matrilin-3 gene 
function in these null mutation mice.  
However, the redundancy within the family has caused problems in this regard and the 
two single gene inactivations performed so far for matrilin-1 and -2 have not yielded 
any change in phenotype. These studies are at present being continued through the 
establishment of double knockouts. Matrilin-1/-3 double knockout mice were generated 
and the biochemical analysis of these mice was the second aim of this dissertation. 
Since matrilins are neither found in Drosophila nor in C. elegans but are present in 
vertebrates, the zebrafish was chosen as a second model organism and gene silencing by 
use of morpholinos employed as an alternative way to elucidate matrilin function.  
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 2. Materials and Methods                
2.1. Characterization of matrilin-3 deficient mice 
2.1.1. Genotyping by PCR 
The genotype of offspring from heterozygous mice was screened by PCR. Mouse tails 
(0.5 cm) were digested with 1 mg/ml proteinase K in 1xPCR buffer at 55oC for 3-5 
hours till all tissues were lysed. 0.5 ul of clear supernatant, which contains genomic 
DNA, was obtained by centrifugation and used for the PCR reaction. DNA polymerase 
and 10x PCR-buffer were from the Expand High Fidelity PCR kit (Roche). 
 
 
Fig. 2-1 Primer location. 
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 The following specific primers were used. 
Designation Sequence (5’-3’) Direction 
mat 372  GCT GAG ACC TCT GAC CCT GTG forward 
mat 373  GGA AGT AGC CAG AGC AGA GAG AT reverse 
cmpm 343 TGC CAC TGG AAT GCA CAG AC forward 
neo2 CCT TCC CGC TTC AGT GAC reverse 
 
The PCR products were electrophoresed on a 2% agarose gel. The expected sizes were 
245 base pairs for the wildtype allele and 836 base pairs for the mutant allele. 
 
Genotyping PCR program: 
Step Time 
Initial denaturation 95°C, 5 min 
Cycle (5 cycles):   
Denaturation 
Annealing (decrease 1°C per cycle) 
Elongation 
 
 
95°C, 45 sec 
64-60°C, 45 sec 
72°C, 2 min 
Cycle (35 cycles):  
Denaturation 
Annealing 
Elongation 
 
 
95°C, 45 sec 
59°C, 45 sec 
72°C, 2 min 
Final elongation 
 
72°C, 10 min 
Cooling 4°C 
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 2.1.2. Genotyping by Southern blot 
2.1.2.1. Dig-labeled probe for Southern blot 
The Dig-labeled nucleic acid probes were used for Southern blot analysis. The 
Dig-labeling was performed by using "PCR Dig probe synthesis kit" from Roche. The 1: 
3 ratio (Dig-dUTP : dTTP) in the Dig probe synthesis mix worked well for labeling 
probes up to 1 kb long. 210 ng of matrilin-3 cDNA (clone 16) was used as template and 
two primers, cmpm 31 and cmpm 37, located in VWA domain were used for PCR. The 
expected fragment size was 477 bp. The synthesized probe was stored at –20oC. 
The PCR products were electrophoresed on a 2% agarose gel and the yield of PCR 
products was about 20 ng/ul. No further purification was needed. 0.25 ul of Dig-labeled 
PCR products was tested (con. 0.5ng/ml) and worked in the Southern blot analysis. 
 
Dig-labeling PCR mix    Dig-labeling PCR program 
Template 
10xPCR-buffer with 15 mM MgCl2 
PCR Dig mix (vial 2)   
DNA polymerase (vial 1)(3.5 U/ul) 
10 uM cmpm31 
10 uM cmpm31 
H2O 
210 ng  
2.5 ul 
0.5 ul 
0.6 ul 
1 ul 
1 ul 
36.9 ul 
Initial Denaturation 
Cycle(30 cycles): 
Denaturation 
Annealing 
Elongation 
Elongation 
Cooling 
95°C, 2 min 
 
95°C, 45 sec 
47°C, 1 min 
72°C, 1 min 
72°C, 10 min 
4°C 
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 2.1.2.2. Genomic DNA extraction 
Murine genomic DNA was prepared from mouse tails (~1 cm) by incubating with 700 
ul lysis buffer (10 mM Tris-HCl, pH 7.5; 0.1 M EDTA, pH 8.0; 0.5% SDS) containing 1 
mg/ml proteinase K (Sigma) at 55oC for 3-5 hours till all tissues were lysed and became 
soft. The extracts were cleared by centrifugation and proteins were removed by 
applying ½ volume of phenol and chloroform. Genomic DNA was precipitated from the 
aqueous phase with 1 volume of isopropanol and pellets were washed with 70% EtOH 
and further dissolved in 50 ul double-distilled water.  
2.1.2.3. Restriction enzyme digestion 
BstXI (purchased from BioLabs) digested murine genomic DNAs were used for 
Southern blot analysis. The restriction enzyme digestion mixture was prepared and 
incubated at 55oC overnight. Digested DNAs were electrophoresed on 0.7% agarose 
gels.  
2.1.2.4. Southern blot 
DNAs were then depurinated by submerging the gel in 0.25 M HCl, with shaking at 
room temperature, for up to 10 min until the bromophenol blue marker changed from 
blue to yellow. Then the DNAs were denatured in denaturation solution twice for 15 
min. The gel was submerged twice in neutralization buffer for another 15 min each in 
order to stop the denaturation reaction. Then the gel was equilibrated in 20x SSC buffer 
for 10 min. The blot transfer was set up by placing the gel on top of a sheet of Whatman 
3 MM paper soaked with 20x SSC solution. A piece of Roti-Nylon plus membrane 
(Roth) to the size of the gel was placed on the DNA-containing surface of the gel, 
avoiding the formation of air bubbles. The blot assembly was completed by adding a 
dry sheet of Whatman 3MM paper, a stack of paper towels, a glass plate, and a weight 
of 200 – 500 g. The blot was transferred overnight at room temperature in 20x SSC 
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 buffer. DNAs were subsequently fixed to the membrane by UV cross-linking. 
Prehybridization was done with 20 ml hybridization buffer only (without probe) in 
heat-sealed plastic bags at 42oC for 2 hours. The blot was hybridized with 5 ng/ml of the 
Dig-labeled DNA probe for final concentration.  
The appropriate amount of labeled probe was withdrawn and diluted into 50 ul of 
double-distilled water in a microcentrifuge tube. The probe was denatured in boiling 
water for 5 min then quickly chilled in an ice bath. The denatured probe was then 
immediately added to a tube containing the appropriate amount of hybridization buffer, 
prewarmed to 42oC and mixed by inversion to form the hybridization solution. The 
amount of hybridization buffer was according to the size of the blot membrane (3.5 ml 
per 100 cm2). 
In order to remove unbound probe, the blot was first washed with low stringency 
washing buffer in a plastic tray twice for 5 min each at room temperature and 
subsequently with high stringency washing buffer twice for 15 min each at 65oC with 
agitation.  
The hybridization solution was stored in a tube at –20oC and could be reused 3-5 times. 
When reusing the probe, it was denatured at 68oC for 10 min and chilled on ice for 
another 10 min. 
After incubation with an anti-Dig Fab fragment antibody (1:20,000) for another 30 min, 
the blot was washed twice in washing buffer for 15 min and equilibrated in detection 
buffer for 2 min. Detection was done with CDP-ready-to-use (Roche) substrate. 
2.1.3. Whole mount skeletal staining 
Newborn mice were deskinned and eviscerated, fixed in 95% EtOH for 3 days, and then 
transferred into acetone for 1 day. Staining was performed in a solution of 90% EtOH, 
5% acetic acid, and 5% H2O supplemented with 0.005% alizarin red S (Sigma) and 
0.015% alcian blue 8GS (Sigma) for 3 days at 37°C. Samples were rinsed in water 
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 and cleared for 3 days in 1% potassium hydroxide followed by clearing in 0.8% 
KOH–20% glycerol for 1 week. Samples were then transferred into 50, 80, and finally 
100% glycerol for long-term storage.  
2.1.4. Immunohistochemistry 
For immunohistochemistry, knees dissected from newborn or 4-week-old animals were 
fixed overnight at 4°C in 95% EtOH / 5% acetic acid, dehydrated in absolute EtOH, and 
embedded in paraffin. Deparaffinization ensued through incubation twice for 5 min in 
xylol. After rehydration, endogenous peroxidases were inhibited in 97% methanol/ 0.9% 
H2O2 at room temperature for 25 min and sections then briefly washed with PBS three 
times for 5 min each. The sections were digested with 0.2% bovine testicular 
hyaluronidase in PBS, pH 5.0, at 37°C for 20 min. After three washing steps, the 
sections were blocked for 1 h with 1% (w/v) bovine serum albumin (BSA) in PBS, pH 
7.2, together with goat serum from ABC kit (3 drops in 10 ml BSA/PBS), then 
incubated with primary antibodies against matrilin-1, -2, -3, -4, collagens II, IX, X or 
aggrecan overnight at 4°C. The primary antibodies were visualized by consecutive 
treatment of sections with biotinylated secondary antibodies at 37°C for 1 h followed by 
avidin-biotin-complex (ABC) reagent (Vectastain) treatment at room temperature for 30 
min. Color was developed by using fresh 3, 3'- diaminobenzidine (DAB) (Sigma) 
staining solution for 5-10 min. The reaction was stopped by rinsing sections in water, 
dehydrating in absolute EtOH, clearing in xylol and mounting in Entellan (Merck) 
solution. All antibodies were diluted in 1% (w/v) BSA/ PBS. 
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 Antibodies 
rabbit anti-matrilin-1 
rabbit anti-matrilin-2 
rabbit anti-matrilin-3 
rabbit anti-matrilin-4 
rat anti-collagen II 
rabbit anti-collagen IX 
rabbit anti-collagen X 
rabbit anti-aggrecan 
Dilution 
1:400 
1:400 
1:400 
1:800 
1:600 
1:400 
1:800 
1:400 
Property 
polyclonal, affinity purified 
polyclonal, antiserum 
polyclonal, affinity purified 
polyclonal, affinity purified 
polyclonal, affinity purified 
polyclonal, affinity purified 
polyclonal, affinity purified 
polyclonal, affinity purified 
 
DAB staining solution 
5 ml DAB stock (stock I) 
45 ml dest. water 
50 ml Tris-HCl (pH 7.6) 
120 ul stock II 
Stock I 
27 mg DAB/ 5 ml dest. water
Stock II 
100 ul 30% H2O2/ 0.5 
ml dest. water 
2.1.5. Northern blot 
Total RNA was isolated from newborn mouse limb cartilage with the Qiagen RNeasy 
kit according to the instructions of the manufacturer. For northern analysis, 5 ug of total 
RNA was size fractionated on a 1% agarose–2.2 M formaldehyde gel and blotted to a 
Hybond XL membrane (Amersham). The membrane was consecutively hybridized with 
32P-labeled cDNA probes specific for mouse matn-1, matn-2, matn-3, matn-4, or 
GAPHD (glyceraldehyde phosphodehydrogenase). 
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 2.1.6. In situ hybridization 
Nonradioactive in situ hybridization on tissue sections for mouse indian hedgehog (Ihh), 
and parathyroid hormone/ parathyroid hormone-related peptide receptor (Ppr) mRNA 
was performed as described (Brandau et al., 2002). Briefly, newborn limbs were fixed 
in 4% PFA in Tris-buffered saline (TBS) (pH 9.5) and subsequently dehydrated and 
embedded in paraffin. Six-um-thick sections were dewaxed, rehydrated, rinsed in TBS 
(pH 7.4), and postfixed with 4% PFA-TBS (pH 9.5) for 10 min. Sections were rinsed in 
TBS (pH 7.4), treated with 10 ug of proteinase K/ml for 30 min at 37°C, acetylated with 
0.25% acetic anhydride for 10 min, washed three times in TBS (pH 7.4), and 
dehydrated in an ascending EtOH series. Air-dried sections were hybridized with 
Dig-UTP-labeled antisense riboprobes overnight at 52°C. After hybridization, sections 
were washed three times for 30 min each at 55°C in 50% formamide, 2x sodium 
citrate-chloride buffer (SSC [1xSSC is 0.015 M sodium citrate and 0.15 M NaCl]), and 
twice in 1xSSC for 15 min at room temperature. The sections were then incubated with 
an alkaline phosphatase-coupled antibody against Dig (Roche) diluted 1:500 in TBS 
(pH 7.4) containing 2% sheep serum and 0.1% Triton X-100 for 2 h at room 
temperature. After rinsing in TBS (pH 7.4), color detection was performed according to 
the manufacturer recommendation. Radioactive in situ hybridization was performed as 
described previously (Aszodi et al., 1998) using [33P]UTP-labeled riboprobes against 
Matn-3. 
2.1.7. Hematoxylin-eosin staining 
For histological analysis, knees or tails dissected from newborn, 4-week-old, 
8-week-old, 12-week-old, 6-month-old and 9-month-old mice were fixed overnight in 
fresh 4% paraformaldehyde in phosphate-buffered saline (PBS, pH 7.2), washed with 
PBS, dehydrated in a graded alcohol series, and embedded in paraffin. Samples from 
mice analyzed after birth were decalcified in 10% EDTA-PBS for one week. After 
embedding in paraffin, sections were cut at 6 to 8 um and stained with 
hematoxylin-eosin.  
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 2.1.8. Van Kossa staining 
The classic van Kossa silver method is used to stain the mineral component in bone, 
calcium phosphate, and is a negative stain for osteoid with the calcium component 
blackened by silver deposition. Nuclei are counterstained red by safranin O. Here a 
modified van Kossa's method for detecting mineralized bone was used.  
Paraffin embedded sections form knees dissected from newborn mice were 
deplasticized with xylol, and hydrated in distilled water. The sections were placed in 
silver nitrate solution (5% in H2O), exposed to strong light for 1 h and the reaction 
terminated when the mineralized bone turned dark brown to black. Sections were 
washed in distilled water three times, 1 min each, then treated with sodium thiosulfate 
(5% in H2O) for 2 to 3 min and washed intensively in distilled water for 2 min. 
Counterstaining was performed in 0.5% safranin O solution (0.35 g in 100 ml distilled 
water) for 20 to 30 sec.  
2.1.9. Safranin orange staining 
Safranin O staining was used to stain proteoglycans in the cartilage sections. Paraffin 
embedded cartilage sections which had been decalcified in 10% EDTA were 
deplasticized with xylol and hydrated in distilled water. Sections were incubated in 
Weigert's iron hematoxylin solution for 3 min and washed in distilled water a few times 
until there was no color present in the water. Then the sections were immersed in 1 % 
HCl-EtOH and washed immediately in distilled water for 10 min. The sections were 
placed in 0.02 % fast green solution for 12 to 15 min and washed again with distilled 
water. The muscle in the section started to become green in this step. The sections were 
then incubated in freshly prepared 1 % acetic acid for 5 min and washed in distilled 
water. Counter staining was performed by use of 0.5 % safranin O solution for 2-3 min 
until the growth plates turned red. The muscle presented a blue color after counter 
staining.  
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 The safranin O solution could be stored for 2-3 days. Solutions were prepared freshly 
when the red color in cartilage became too weak. 
Weigert's solution 
mix stock A and stock B  
in 1:1 ratio. 
Stock A 
1 g hematoxylin 
100 ml EtOH 
Stock B 
FeCl2. 6H2O       2 g 
25 % HCl         1 ml 
distilled water     95 ml 
2.1.10. TRAP staining 
Osteoclasts activity was detected through staining for tartrate-resistant alkaline 
phosphatase (TRAP) by using a leukocyte acid phosphatase kit (Sigma). Paraffin 
embedded sections of knees dissected from newborn mice were deplasticized with xylol 
and hydrated in PBS. The slides were incubated in a cuvette which contained solution A 
(see below) at 37oC for 1 h, protected from light. After 1 hour, the slides were rinsed 
thoroughly in deionized water and mounted in Aquamount solution. 
Solution A 
45 ml 37oC deionized water 
1 ml diazotized fast garnet GBC 
0.5 ml naphthol AS-BI phosphate solution 
2 ml acetate solution 
1 ml tartrate solution 
Diazotized fast garnet GBC 
Mix 0.5 ml fast garnet GBC base 
solution with 0.5 ml sodium nitrite 
solution by gentle inversion for 30 sec 
and let stand for 2 min 
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 2.1.11. Glycosaminoglycan assay 
The stable dimethylmethylene blue (DMB) solution was prepared by dissolving 21 mg 
of DMB in 5 ml of absolute EtOH containing 2 g of sodium formate. The volume was 
set to 1 liter with distilled water and the pH was adjusted to 1.5 using concentrated 
formic acid.  
The standard curve was made with serial 1:2 dilutions of chondroitin 6-sulfate (c-6-5, 
Fluka, cat no 27043) in water with 10 mg/ml as starting concentration. Samples from 
cartilage extractions were precipitated with 96% EtOH and dissolved in 100 ul of 4 M 
GuHCl.  
The glycosaminoglycan-dimethylmethylene blue complex was not stable and started to 
aggregate as soon as glycosaminoglycan and dye were mixed. This was seen as a slow, 
progressive decrease of absorbance at 525 nm during the first 10 min. Vigorous mixing 
accelerated the precipitation process. Therefore, 100 ul of each chondroitin 6-sulfate 
dilution or sample were first placed in disposable plastic cuvette, 625 ul of DMB 
solution gently added to the cuvette and the sample then mixed by gently pippeting up 
and down once. The absorbances were determined at 525 nm and measured 15 sec after 
mixing.  
GAG assay standard curve
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Fig. 2-2 Standard curve of glycosaminoglycan assay. 
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 2.1.12. Cartilage extraction 
Knee joints and sterna were dissected and frozen at -80°C. On the day of extraction, the 
specimens were cut into 1 mm3  pieces. 10 ml volumes of chilled buffer 1 (0.15 M NaCl, 
50 mM Tris, pH 7.4) were added per gram of wet tissue and the tissue was extracted for 
7 to 10 h at 4°C with continuous mixing. The extracts were clarified by centrifugation, 
and the supernatants stored at -20°C. The pellets were reextracted in an identical 
manner with buffer 2 (1 M NaCl, 10 mM EDTA, 50 mM Tris, pH 7.4), and the 
remaining insoluble material extracted with buffer 3 (4 M GuHCl, 10 mM EDTA, 50 
mM Tris, pH 7.4). All extraction buffers contained 2 mM phenylmethylsulfonyl 
fluoride and 2 mM N-ethylmaleimide. 100 ul aliquots of the extracts obtained with 
buffers 1, 2, and 3 were precipitated with 1 ml of 96% EtOH overnight at 4°C. The 
precipitates were washed with a mixture of 9 volumes of 96% EtOH and 1 volume of 
TBS for 2 h at 4°C with gentle agitation. After centrifugation, the pellets were air dried 
and suspended in 150 ul of water and the same volume of 2x nonreducing SDS-PAGE 
sample buffer was added. Aliquots were applied to 4-15% SDS-polyacrylamide gels. 
SDS-PAGE was performed as described by Laemmli (Laemmli, 1970). 
2.1.13. Western blot 
Western blots were conducted according to standard protocols with some minor 
modifications. After being separated in SDS-PAGE, proteins were electrically 
transferred to nitrocellulose membrane in 10% methanol/ 50mM boric acid, pH 8.5, at 
400 mA for 1 hour or 100 mA over night in the cold room. After confirming transfer 
efficiency and protein load by Ponceau S staining, the membrane was blocked with 5% 
low-fat milk powder in TBS for 20 min. Subsequently, appropriate affinity-purified 
rabbit antibodies diluted in TBS were applied. Bound antibodies were detected by 
luminescence using peroxidase-conjugated immunoglobulin G (Dako), 
3-aminopthalhydrazide (1.25 mM), p-coumaric acid (225 µM), and 0.01% H2O2. The 
"Super RX" film from Fuji was used for exposure.    
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 Antibodies 
rabbit anti-matrilin-1 
rabbit anti-matrilin-2 
rabbit anti-matrilin-3 
rabbit anti-matrilin-4 
rabbit anti-rat COMP 
mouse anti-chick collagen II 
rabbit anti-mouse biglycan 
rabbit anti-mouse decorin 
Dilution 
1:500 
1:500 
1:400 
1:500 
1:1600 
1:1000 
1:3000 
1:1000 
Property 
polyclonal, affinity purified 
polyclonal, antiserum 
polyclonal, affinity purified 
polyclonal, affinity purified 
polyclonal, antiserum 
monoclonal antibody; II-II6B3 
LF-106, from NIH, Dr. L. Fisher, 
antiserum 
LF-113, from NIH, Dr. L. Fisher, 
antiserum 
 
2.2. Characterization of matrilin-1/-3 double null mice 
2.2.1. Double fluorescence analysis for matrilin-4 and –1 in 
western blots of cartilage extracts 
Knee and sternal protein extracts derived from newborn and 4-week-old mice were 
dissected as described for matrilin-3 single null mice. Proteins were separated by 
non-reducing SDS polyacrylamide gel electrophoresis and subsequently blotted onto a 
nitrocellulose membrane. Specific antibodies against matrilin-4 and matrilin-1 raised in 
different species were applied. Bound antibodies were detected by infrared fluorescence 
using Alexa Fluor® 680-labeled anti-rabbit (Molecular Probes) and IRDyeTM 800 
conjugated affinity purified anti-chicken immunoglobulin G (Rockland). The 
fluorographs were developed with the ODYSSEY infrared imaging system (LI-COR 
Biosciences) 
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 Antibodies Dilution Property 
chicken anti-bovine matrilin-1 1:50 polyclonal, affinity purified 
rabbit anti-mouse matrilin-4 1:500 polyclonal, antiserum 
IRDye-800 anti-chicken IgG 1:10,000 green fluorescence; Rockland 
Alex-680 anti-rabbit IgG 1:10,000 red fluorescence; gift from Prof. T. 
Langer 
 
2.3. Characterization of zebrafish matrilins 
2.3.1. Expression and purification of recombinant 
matrilin-1, -3a, -3b and –4 VWA1 domains 
cDNAs coding for zebrafish matrilin-1, -3a, -3b and -4 VWA1 domains were generated 
by PCR on the full-length cDNA. Suitable primers (see Table) introduced 5’-terminal 
NheI and 3-terminal NotI restriction sites. The cDNA was inserted into the expression 
vector pCEP-Pu downstream of the sequences encoding the BM-40 signal peptide 
(Kohfeldt et al., 1997) and an N-terminal His6-tag (Smyth et al., 2000). The recombinant 
plasmids were introduced into HEK-293/ EBNA (Epstein–Barr nuclear antigen) cells 
(Invitrogen) by transfection with FuGENETM 6 (Roche). Following selection with 
puromycin (1 ug/ml) the cells were transferred to serum-free medium for harvesting of 
the recombinant protein. After filtration and centrifugation (1 h, 10,000g), cell culture 
supernatants containing the N-terminally His6-tagged matrilin-1, -3a and –4 VWA1 
domains were applied to TALON metal affinity columns (1 ml; BD Biosciences). After 
washing with 5 mM imidazole in buffer A (0.1 M NaCl, 20 mM Tris, 50 mM NaH2PO4, 
pH 8.0), the bound protein was eluted with 0.25 M imidazole in buffer A containing 
0.2% sodium azide. The purity of proteins was further confirmed by electrophoresis on 
Materials and Methods 50
 a 12% SDS-polyacrylamide gel. 
In the case of purification of matrilin-4 VWA1 domain, fast protein liquid 
chromatography (FPLC) was applied since an albumin contamination was observed in 
the fraction eluted from the TALON metal affinity column. A column of Superdex 200 
HR 10/30 (Amersham Pharmacia) was employed and saturated in buffer A (0.1 M NaCl, 
20 mM Tris, 50 mM NaH2PO4, pH 8.0) with a flow rate of 0.5 ml/ min. Protein purity 
was further confirmed by electrophoresis on a 12% SDS-polyacrylamide gel before 
immunization. 
 
Primers for expression VWA1 domains of zebrafish matrilins 
Designation Sequence (5’-3’) Direction 
zmat1F CAATGCTAGCAGGTCTGTGTAACACCAAGCCCAC forward 
zmat1R CAATGCGGCCGCTTAACCGCACAATGTCTCCCGG  reverse 
zmat3aF CAATGCTAGCTACAGATTCACAGTGTAGG forward 
zmat3aF CAATGCGGCCGCTTAACCGCACAATGTCTCCCGG reverse 
zmatn3bF CAATGCTAGCAGAGCCCTGCAAGAG forward 
zmatn3bR CAATGCGGCCGCTTAACCACAGAGCGTTTCCC reverse 
zmat4F CAATGCTAGCGTGTAAATCTGGCCCGGTTG forward 
zmat4R CAATGCGGCCGCTTACCCGCAGAGCTTGTCTTGG reverse 
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 2.3.2. Preparation of antibodies against matrilin-1, -3a and 
-4 
The purified matrilin-1, -3a and -4 VWA1 domains were used to immunize rabbits. The 
antisera obtained were purified by affinity chromatography on columns with the original 
antigens coupled to CNBr-activated Sepharose (Amersham Biosciences). The specific 
antibodies were eluted with 0.1 M glycine, pH 2.5, and the eluate was immediately 
neutralized through addition of 1 M Tris-HCl, pH 8.8. 
Since cross-reactivity of antisera with other members of the matrilin family was 
observed, affinity purified antibody against for example matrilin-4, was first depleted by 
applying it to affinity chromatography columns containing bound matrilin-1 and 
matrilin-3a with a slow flow rate of 100 ul/ min in the cool room in a closed system for 
about 30 hours. Then the flow through, which should contain antibodies against 
matrilin-4, was collected. The cross-reactivity was checked by ELISA analysis.  
2.3.3. Determination of cross-reactivity of antibodies against 
each matrilin with the other matrilins  
ELISA analysis was performed to test for cross-reactivities. Affinity purified 
recombinant VWA1 domain matrilin proteins were coated with 0.5 ug/ well on 
immunoplates (Nunc F96 Max sorp, cat. 442402) at 37oC for 4 hours. After blocking 
with 5% low-fat milk powder dissolved in PBS, 100 ul/ well of a serial dilution of 
affinity purified antibodies were added and further incubated at 37oC for another hour. 
Subsequently alkaline phosphatase-conjugated swine anti-rabbit IgG (Dako) was 
applied for one hour. After a 30-min incubation with the substrate, 
4-nitrophenylphosphate disodium salt hexahydrate (pNPP) (Fluka 71768), bound 
antibodies were determined in an ELISA reader at 405 nm. The substrate was dissolved 
in 10% diethanolamin/ 0.5 mM MgCl2, pH 9.8.  
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 A strong cross-reactivity of antibodies against matrilin-1 with the matrilin-3b VWA1 
domain was observed and it was not possible to deplete this cross-reactivity on a 
matrilin-3b affinity column. Therefore a preincubation of the antibody with recombinant 
matrilin-3b VWA proteins was performed in order to eliminate the matrilin-3b titer. 
Serially diluted antibodies against matrilin-1 were incubated with 0.1 ug/well of 
recombinant matrilin-3b VWA1 protein at 37oC for 3 to 4 hours prior to application to 
the ELISA plate. Other procedures were as in the ELISA protocol above. 
2.3.4. Determination of cross-reactivity of the antibody 
against matrilin-3a with matrilin-3b 
Cell culture supernatant of HEK-293/EBNA cells transfected with cDNA coding for the 
zebrafish matrilin-3b VWA1 domain was subjected to SDS/PAGE together with a 
dilution series of purified zebrafish matrilin-3a VWA1 domain. After transfer onto 
nitrocellulose the immunoblot was incubated with the affinity-purified zebrafish 
matrilin-3a specific antibody diluted in TBS containing 5% low fat milk powder. The 
bound antibodies were detected by luminescence using peroxidase-conjugated swine 
anti-rabbit IgG (Dako), 3-aminophthalhydrazide (1.25 mM), p-coumaric acid (225 uM) 
and H2O2 (0.01%). 
2.3.5. Whole mount immunostaining 
Zebrafish larvae [5 dpf (days post fertilization)] were fixed overnight at 4oC in 4% PFA 
in PBS, pH 7.4, washed in PBT (PBS containing 0.1% Tween) and finally washed and 
stored in methanol at –20oC. To bleach pigment and block endogenous peroxidases, 
larvae were incubated overnight in 3 ml of 10% H2O2 in methanol, then 10 ml of PBT 
was added and the incubation continued for further 16 to 24 h. Larvae were washed in 
PBT, digested with 2 ug/ml proteinase K for 8 min and fixed again in 4% PFA for 15 
min. After washing, larvae were treated with hyaluronidase (Sigma; 500 units/ml in 0.1 
M NaH2PO4, 0.1 M sodium acetate, pH 5.0) at 37oC for 2 h and blocked in 3% normal 
goat serum for 2 h. Affinity purified antibodies were applied at appropriate dilutions 
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 (matrilin-1 and -3a, 1:1000; matrilin-4, 1:500) and the specimens were incubated for 2 
h.  
The primary antibodies were visualized by consecutive treatment of larvae for 2 h each 
with the biotinylated secondary antibody and a streptavidin–peroxidase conjugate (ABC 
kit, Vectastain). All antibodies were diluted in 3% (w/v) normal goat serum in PBT. For 
color development, larvae were pre-soaked in diaminobenzidine (0.2 mg/ml PBT) for 
30 min and 1 ul of 0.3% H2O2 solution was added while the larvae were observed under 
a dissection microscope. For detailed analysis, larvae were post-fixed in 4% PFA for 15 
min, washed in PBT and gradually transferred into 90% glycerol. Except for when 
indicated, all procedures were carried out at room temperature (20oC). Occasionally, 
specimens were kept overnight at 4oC between steps in the staining procedure. 
2.3.6. Immunostaining on sections 
Adult fish were euthanaized by an over dose of ethyl-m-aminobenzoate 
methanesulfonate (tricaine) and fixed in 4% PFA/PBS over night at 4oC. After washing 
with PBS twice, 45 min each, fish were dehydrated in 70%, 80%, 90% and 96% EtOH 
for 10 min each and finally in 100% EtOH for 20 min twice. Subsequently, fish were 
incubated in 50% xylol/50% EtOH for 20 min and then in 100% xylol twice for 20 min 
each. Next, paraffin type 3 (Richard-Allan Scientific) was allowed to penetrate fish for 
at least 1h at 68oC followed by paraffin type 6 (Richard-Allan Scientific) for a few 
hours. Finally, fish were embedded in paraffin type 6 and stored at 4oC. 
Immunostaining was performed on paraffin-embedded sections of 5 dpf and 
4-month-old zebrafish. Sections were deparaffinized by two 5-min incubations in xylol. 
After rehydration in PBS, the sections were digested with hyaluronidase (500 units/ml 
in 0.1 M NaH2PO4, 0.1 M sodium acetate, pH 5.0) at 37oC for 30 min. After washing, 
the sections were blocked with 5%(w/v) BSA in TBS for 1 h and incubated with the 
affinity-purified antibody overnight at 4oC. The primary antibodies were visualized by 
consecutive treatment with biotin–streptavidin–peroxidase-conjugated goat anti-rabbit 
IgG (Dianova) and alkaline phosphatase conjugated streptavidin (Dianova) for 1 h each. 
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 Antibodies and enzyme conjugates were diluted in 1% (w/v) BSA in TBS and the slides 
developed with FASTTM Fast Red TR/naphthol AS-MX (Sigma). Immunofluorescence 
microscopy was performed as described previously (Klatt et al., 2000) using the 
affinity-purified rabbit antibodies against the zebrafish matrilin VWA1 domains and a 
Cy3-conjugated affinity-purified anti-rabbit IgG as secondary antibody. 
 
Antibody dilutions 
Designation Whole mount staining IHC on section 
1za1 1:1000 1:1000 
3aza1 1:1000 1:1000 
4za1 1:500 1:250 
Goat anti rabbit- HRP (ABC kit) 1:200  
Cy3-Goat anti rabbit  1:400 
Biotin-SP-Goat anti rabbit  1:1000 
AP-streptavidin  1:500 
 
2.3.7. Temporal expression analysis by RT-PCR 
Primers were designed according to EST and genomic sequences deposited in the 
databases (see Table).  
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 Designation Sequences (5’-3’) Direction 
m1z3 CAGTCTGTCTCTGGTTTTGG forward 
m1z4 GAACTCCTGCTTCACAGTG reverse 
m3az3 AGCAAGCAATCACCCGTATC forward 
m3az4 TTGCTCACACAAACGTGCTGAC reverse 
m3bz2 AGGCACGACGAAGATCAAAC reverse 
m3bz4  GGTCAAAACTCTCACCGTG forward 
m4z1  GCATGAGTGTGTGAGTGTCC forward 
m4z4  TTGATCTCGTCTTTGCTGTG reverse 
 
2.3.8. Whole mount skeletal staining 
5-day-old larvae were killed by an overdose of 0.2% tricaine and subsequently fixed in 
4% paraformaldehyde in PBS at room temperature for several hours. Specimens were 
stained for cartilage as described (Piotrowski et al., 1996). The larvae were transferred 
into a 0.1% alcian blue solution dissolved in 80% EtOH/20% glacial acetic acid over 
night. After staining, the larvae were rinsed in EtOH and gradually rehydrated into PBS. 
They were then transferred into a solution of 1% KOH/3% H2O2 for about 1 hour to 
bleach all pigmentation. Subsequently, the tissue was softened in a 0.05% trypsin 
solution (Sigma), dissolved in saturated sodium tetraborate for another 4 hours and 
cleared in 18% glycerol/ 0.8% KOH/ 0.2% Triton x-100/PBS. The specimens were 
stored in 70% glycerol/30% phosphate-buffered saline at 4oC. The specimens were then 
photographed with a Leica MZFL111 microscope. 
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 2.3.9. Morpholino microinjection 
Zebrafish (Danio rerio) of the Cologne wildtype strain (obtained from the Institute for 
Developmental Biology, University of Cologne, Germany) were used throughout these 
studies. They were maintained at 28oC and embryos were staged according to Kimmel 
et al. (Kimmel et al., 1995). Morpholino antisense oligonucleotides were designed by 
and obtained from Gene-Tools Inc.. Morpholinos covered the ATG translational start 
codon resulting in translational inhibition. All the morpholino oligonucleotides were 
dissolved in 1x Danieau buffer (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM 
Ca(NO3)2, 5.0 mM HEPES; pH 7.6) at a concentration of 1 mM and stored at –20oC. 
Morpholinos were generally diluted to 0.5 mM in 1x Danieau buffer and 0.2% phenol 
red was added as color indicator prior to injection. Morpholino oligonucleotides were 
injected in a volume of 2 to 10 nl into the yolk sac of one-cell embryos just beneath the 
animal cell. Embryos were kept in embryo buffer (5 mM NaCl, 0.17 mM KCl, 0.33 mM 
CaCl2, 0.33 mM MgSO4, 1.68 mM HEPES, pH 7.0) at 28°C for further analysis.  
 
Morpholino oligonucleotides sequences: 
Designation Sequences (5’-3’) 
Matn1 CGGCAATGTCATACTGTAGCGCGGC 
Matn1-5mis CGGg*AATcTCATAgTGTAGaGCcGC 
Matn3z (3a) GAAGGACTTCATTGTCTCGCTGTTC 
Matn3z-5mis GAAcGAgTTCATTcTCTCcCTcTTC 
Matn4 CCCAATCTCACCACAAAAACCCCAG 
Matn4-5mis CCgAATgTCACCAgAAAAAgCCgAG 
Std. Negative control CCTCTTACCTCAGTTACAATTTATA 
Chordin ATCCACAGCAGCCCCTCCATCATCC 
Small letters indicate the mismatch positions. 
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 3. Results                              
3.1. Matrilin-3 deficient mice 
3.1.1. Generation of matrilin-3 deficient mice  
(done by Dr. A. Aszodi and Dr. R. Wagener prior to the start of my dissertation) 
The genomic DNA of mouse matrilin-3 gene contains 8 exons. The mouse matrilin-3 
gene (matn3) was inactivated by homologous recombination in ES cells with a targeting 
vector in which a part of exon 1 was replaced by a neomycin resistance cassette (Fig. 
3-1 A). The targeting strategies were as following: The exon 1 fragment, which encodes 
the signal peptide and the positively charged region, was cut out with XbaI and 
subcloned into the vector pKS (named pKS-Xba vector). Then, in the pKS-Xba vector, 
the 5’ part end of exon 1 was cut by SmaI, which in turn resulted in a blunt-end linear 
fragment. The insert, a neomycin resistance cassette, was prepared from the pGK vector 
by cutting at XbaI and Sal I sites, and Klenow polymerase was used to fill in 5’ 
overhangs. Next, the neomycin resistance cassette gene was ligated into pKS-Xba 
vector. Finally, the recombinant exon 1 was conjugated with upstream and downstream 
genomic sequences. 
The targeting vector was transfected into ES cells and selected with G418. Out of 360 
ES cell clones surviving the G418 selections, eight correctly targeted clones were 
identified by Southern blot analysis of BstXI-digested genomic DNA using an external 
probe (Fig. 3-1). ES cells from two targeted clones were used to generate germ line 
chimeric males, which were subsequently mated with C57/B6 females to generate 
heterozygous offspring. Heterozygous breeding produced wildtype, heterozygous, and 
mutant offspring (Fig. 3-1). Thereafter, two inbred strains were generated by 
backcrossing homozygous males with either 129/sv or C57/B6 females.  
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Fig. 3-1 Targeted disruption of mouse Matn-3. (A) Structure of the mouse Matn3 gene, targeting 
construct, and targeted allele after homologous recombination. Black and open boxes indicate the 
translated and untranslated regions of exons (1 to 8), respectively. The expected fragment sizes for 
wildtype and targeted alleles are 10 and 8 kb, respectively, following digestion with BstXI and 
hybridization with the indicated external probe (p). neo, neomycin cassette. (B) Southern blot analysis of 
genomic DNA from ES cell clones shows the wildtype (10 kb) and the targeted (8 kb) alleles. (C) 
Southern blot analysis of tail DNA isolated from a mouse homozygous for the wildtype allele (-/-), a 
heterozygous mouse (-/-), and a homozygous mutant mouse (-/-). (D) Immunohistochemistry using a 
matrilin-3-specific antibody on tissue sections from embryonic day 13.5 embryo confirms the lack of 
matrilin-3 in the mutant. m, mutant; wt, wild type. (E) In situ hybridization shows the absence of 
matrilin-3 mRNA in a homozygous mutant embryo. 
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 3.1.1.1. Genotyping of offspring 
Matrilin-3 mutant mice were obtained by mating heterozygous parents. Mutant newborn 
offsprings were identified by genomic PCR while at other ages the mice were 
genotyped by Southern blot analysis.   
The primers used in PCR genotyping were located as indicated in Fig. 2-1. Mouse tail 
genomic DNA was prepared by incubation in 1x PCR buffer with 0.4 mg/ml proteinase 
K at 55oC for 3 to 5 hours. Supernatants were cleared by centrifugation and diluted 1:10 
in H2O. 0.5 ul of diluted supernatant was used as template in the PCR reaction. The 
expected fragment size was 245 base pairs for the wildtype allele and 836 base pairs for 
the mutant allele. 
For Southern blot analysis, genomic DNA was isolated from mouse tails by incubation 
in lysis buffer and further purified by phenol-chloroform extraction and isopropanol 
precipitation (see Materials and Methods for detail). Purified genomic DNA was 
digested with BstXI and hybridized with the Dig-labeled probe, binding to a sequence in 
exon 2, as shown in Fig. 3-1 A. The expected fragment size after BstXI enzyme 
digestion was 10 kb for the wildtype allele and 8 kb for the recombinant allele. 
The null mutation was confirmed on tissue sections at embryonic day 13.5. 
Immunohistochemistry using an affinity-purified rabbit polyclonal antibody against 
matrilin-3 and in situ hybridization using an antisense RNA probe demonstrated the 
complete absence of the matrilin-3 protein and mRNA in homozygous mutant mice, 
respectively (Fig. 3-1 D and E).  
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 3.1.2. Gross morphology of the skeleton is normal in 
matrilin-3 deficient mice 
Matrilin-3 deficient mice showed no obvious abnormalities in size, gross morphology 
and motor behavior up to 15 months of age (not shown). They were fertile and had 
normal life spans. Since matrilin-3 is expressed by chondrocytes and osteoblasts during 
endochondral bone formation, first the gross skeletal morphology of newborn and adult 
mutant mice was analyzed.  
Whole mount staining with alcian blue (for cartilage) and alizarin red (for bone) of 
newborn mice revealed that all bones of the appendicular, axial, and craniofacial 
skeleton formed normally in Matn-3 null mice (Fig. 3-2 A). A closer view of the limbs 
(Fig. 3-2 B, C), rib cage (Fig. 3-2 D), trunk region (Fig. 3-2 E), and the base of the skull 
(Fig. 3-2 F) showed no evidence of size reduction or any malformation in mutants 
compared to controls. Furthermore, careful measurement of the length of skeletal 
elements of the hind limbs and forelimbs demonstrated no significant difference 
between homozygous mutant mice and wildtype mice (Fig. 3-2 G). Taken together, 
these data indicate that the lack of matrilin-3 has no impact on normal skeletal growth. 
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Fig. 3-2 Analysis of the skeletal anatomy in wildtype and matrilin-3-deficient mice. (A) Whole mount 
staining shows that newborn mutant (m) mice have a skeletal structure that does not differ from that of 
wildtype (wt) mice. The size and the appearance of the long bones of the limbs (B), rib cage (D), trunk 
(E), and the base of the skull (F) are indistinguishable between wildtype and mutant littermates. (G) There 
is no statistically significant difference in the length of the long bones of newborn limbs between 
wildtype and mutant mice (n = 5). Error bars represent ± standard errors of the mean. Abbreviations: h, 
humerus; u, ulna; r, radius; f, femur; t, tibia.  
3.1.3. Matrilin-3-deficient mice show normal endochondral 
bone formation and intervertebral disk development 
To investigate the skeletal development of the Matn-3 null mice in greater detail, 
histological, immunohistological and in situ hybridization analyses were performed. 
Haematoxylin-eosin staining of tibias derived from newborn mice, 4-week-old and 
8-week-old mice and tails from 4-week-old, 12-week-old and 9-month-old mice were 
examined. The results showed a normal columnar chondrocyte arrangement and growth 
Results 62
 plate architecture in the proliferating zone of newborns (Fig. 3-3A, B) and in the growth 
plate of older mice (Fig. 3-3 C-F). The appearance of the primary and secondary 
ossification centers were identical in control and null mice (Fig. 3-3). Similar to that of 
long bones, the development of intervertebral disks was normal in Matn-3 null mice 
(Fig. 3-4). Safranin orange staining for proteoglycans showed no sign of degenerative 
changes of the articular cartilage in mutants up to 9 months of age (Fig. 3-5). 
 
Fig. 3-3 Histological analysis of skeletal development. HE staining of the proximal part of the tibia from 
newborn wildtype (wt) and mutant (m) mice (A,B) and the knee region from 8-week-old mice (C,D) 
shows comparable size and ultrastructure between control and mutant. (E,F) The columnar organization 
in the growth plate of 4-week-old control and mutant mice is identical. rc, resting cartilage; pc, 
proliferating cartilage; hc, hypertrophic cartilage; ac, articular cartilage; gp, growth plate. 
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Fig. 3-4 HE staining shows normal intervertebral disk formation of 4-week-old (4w), 12-week-old (12w) 
and 9-month-old (9m) mutants (mt) and wildtype (wt) mice. No difference in morphology between wt 
and mt was seen. np, nucleus pulposus; ia, inner annulus; oa, outer annulus; gp, growth plate. 
 
Fig. 3-5 Safranin orange staining of the tibial head at 8 weeks (8w), 3 months (3m), 6 months (6m) and 9 
months of age gives no indication of degenerative changes in the articular cartilage in mutants.  
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 Further, we investigated markers for chondrocyte differentiation in the mutant long 
bones. Immunostaining of the humerus from newborn mice showed the normal 
deposition of the typical cartilage proteins, including collagen II, collagen X, and 
aggrecan (Fig. 3-6 A). In situ hybridization of tibial sections with riboprobes for indian 
hedgehog (Ihh), and parathyroid hormone/parathyroid hormone-related peptide receptor 
(Ppr) revealed a normal differentiation of mutant growth plate chondrocytes (Fig. 3-6 
B).  
 
 
Fig. 3-6 Cartilage differentiation and bone development are normal in Matn-3 null mice. (A) 
Immunohistochemistry shows normal deposition of cartilage-specific proteins. Consecutive sections of 
the humerus from wildtype (wt) and mutant (m) mice were stained with antibodies against type II 
collagen (Col2), aggrecan (Agn), and type X collagen (ColX). (B) In situ hybridization with probes 
specific for indian hedgehog (Ihh), and parathyroid hormone/parathyroid hormone-related peptide 
receptor (Ppr) mRNA shows similar expression of these growth plate differentiation markers in wildtype 
and mutant newborn tibial sections. 
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 During development, the cartilage tissue is gradually replaced by bone tissue in a 
process called endochondral ossification. It begins with the transformation of the 
perichondrium into a bone-producing periosteum. Calcification occurs by the deposition 
of calcium salts. This is the first indication of bone formation and the site where it 
occurs is called the primary center of ossification. The perichondrium in this area now 
contains an inner layer of osteogenic cells which differentiate into osteoblasts. These 
cells synthesize and secret the materials which form the intercellular matrix and soon a 
bony collar becomes visible around the cartilage of the center of ossification. Vessels 
enter from the periosteum and carry other osteogenic cells, or osteoblasts, with them. As 
a result, the diaphysis becomes encased in compact bone.  
To check whether the speed of bone development was changed in matrilin-3 null mice, 
van Kossa staining was applied to newborn tibia sections to stain for calcium phosphate 
deposition. The results showed no distinguishable difference between wildtype (Fig. 3-7 
A) and null mice (Fig. 3-7 B), indicating that both the ossification of the bony collar and 
the trabecular bones occurs normally in mutants. Osteoblast and osteoclast activities 
were also examined by alkaline phosphatase and tartrate-resistant alkaline phosphatase 
(TRAP) staining and results showed normal numbers of osteoblasts and osteoclasts, 
respectively (Fig. 3-7 C-F). The vascular invasion front of the growth plate cartilage 
was investigated by immunostaining for endomucin as a marker for endothelial cells 
(Brachtendorf et al., 2001). No difference was observed in vascularization between 
wildtype and mutant growth plates (Fig. 3-7 G, H). 
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Fig. 3-7 Van Kossa staining (A, B) indicates normal mineral deposition in the tibia of newborn mutant 
mice. The sections were counterstained with safranin orange. (C, D) Alkaline phosphatase histochemistry 
(blue staining) shows that differentiation and activity of osteoblasts are normal in mutant mice. (E, F) 
Staining for tartrate-resistant acid phosphatase (TRAP) activity (red staining) indicates comparable 
numbers of osteoclasts in wildtype and mutant long bones. (G, H) Immunostaining for endomucin, a 
marker for vascular endothelial cells, shows a normal vascular invasion front in the mutant growth plate. 
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 3.1.4. Normal expression of other members of the matrilin 
family in matrilin-3-deficient skeletal tissues 
To address the question of whether the lack of an apparent skeletal phenotype in the 
Matn-3 null mice is due to compensation by structurally and functionally related 
proteins, we analyzed the expression of other members of the matrilin family using 
various methods.  
Northern hybridization of total RNA isolated from newborn limb cartilage demonstrated 
that the steady-state levels of Matn-1, Matn-2, and Matn-4 mRNAs were not 
significantly altered in mutant mice compared to those in wildtype mice (Fig. 3-8).  
 
 
Fig. 3-8 Northern blot analysis. (A) A representative northern blot analysis of total RNA isolated from 
wildtype (wt) and mutant (m) newborn limb cartilage. The filter was consecutively hybridized with 
probes specific for Matn1-4 and GAPDH. (B) Diagram showing the percentage of Matn1, Matn2, and 
Matn4 mRNA levels in the mutant compared to that of the wild type (n = 3). The hybridization intensities 
were normalized to the amount of GAPDH mRNA. Error bars represent standard errors of the mean. 
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The tissue distribution patterns of all matrilins were also examined on newborn tibia 
sections using specific polyclonal antibodies. Immunostaining of newborn tibias 
revealed that matrilin-3 was distributed in the epiphyseal and growth plate cartilage but 
was absent at the superficial zone of the epiphyses in normal animals (Fig. 3-9 A). No 
matrilin-3 was detected in mutant mice (Fig. 3-9 B). Matrilin-2 was expressed in the 
perichondrium-periosteum, in the superficial zone, and very weakly in the hypertrophic 
zone of growth plate (Fig. 3-9 E), while matrilin-1 showed the same staining pattern as 
matrilin-3 (Fig. 3-9 C). Matrilin-4 was expressed in whole growth plate and epiphyseal 
cartilage including superficial zone of the epiphyses in normal animals (Fig. 3-9 G). 
Immunostaining for matrilin-1, -2 and –4 in mutant tissue revealed no alterations in 
either distribution or staining intensity compared to those of the wildtype (Fig. 3-9 D, F 
and H).  
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Fig. 3-9 Immunohistochemical staining of developing bones for matrilins on cconsecutive sections of the 
tibia from wildtype (A, C, E, and G) and matrilin 3-deficient (B, D, F, and H) mice. Newborn littermates 
were stained with specific antibodies against matrilin-1, matrilin-2, matrilin-3, and matrilin-4. hc, 
hypertrophic cartilage; pc, proliferating cartilage; rc, rest cartilage. The arrow indicates a ligament. 
 
Tail sections were also examined at 4-weeks of age. Matrilin-3 was strongly expressed 
in the cartilage of inner annulus, articular surface and growth plate, but absent in the 
outer annulus and the nucleus pulposus (Fig. 3-10 A). Matrilin-3 deficient cartilage did 
not stain for matrilin-3. (Fig. 3-10 B), whereas matrilin-1 was expressed weakly in the 
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 growth plate (Fig. 3-10 C, D). Matrilin-2 expression could be detected neither in 
wildtype nor in mutant mice (Fig. 3-10 E, F). Matrilin-4 was expressed identically in 
growth plate in wildtype mice and in mutant mice (Fig. 3-10 G, H). 
 
 
Fig. 3-10 Immunohistochemical localization of matrilins in wildtype (wt) and matrilin-3 deficient (mt) 
vertebral columns. Sagittal sections of the vertebrae from 4-week-old wildtype (+/+; A, C, E, and G) and 
matrilin-3 deficient (mt) (-/-; B, D, F, and H) mice were stained with specific antibodies against matrilin-3 
(matn3), matrilin-1 (matn1), matrilin-2 (matn2), and matrilin-4 (matn4). In the wildtype (A), matrilin-3 
was present in the cartilage of inner annulus (ia), articular surface and growth plate, but absent in the 
outer annulus (oa) and the nucleus pulposus (np). Matrilin-3 deficient cartilage lacked matrilin-3. (B), 
while matrilin-1 (C and D) weak expresssed in growth plate. Almost no matrilin-2 (E and F) expression 
can be seen neither in wildtype nor in mutant mice. Matrilin-4 (G and H) was expressed in growth plate in 
wildtype as well as in mutant mice. np, nucleus pulposus; ia, inner annulus; oa, outer annulus; gp, growth 
plate. The arrow indicates the articular cartilage. 
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 3.1.5. Biochemical analyses reveal no difference in matrix 
protein content in matrilin-3 null mice 
From the skeletal analysis, based on histological and immunohistological staining, there 
was no obvious phenotype in matrilin-3 null mice. Since matrilins have been proposed 
to function as adaptor proteins in the extracellular fibrous network, the lack of 
matrilin-3 protein could, potentially, result in weaker interactions between matrix 
proteins.  
In order to test this hypothesis, cartilages from sternum and knee were isolated and 
extracted sequentially with buffers of different strength. Buffer 1 contained only TBS in 
order to wash out blood and very loosely bound proteins. Buffer 2 contained high salt 
and EDTA and therefore proteins which are immobilized by divalent cation dependent 
interactions were solubilized in this step. In the last step 4 M GuHCl was used in order 
to solubilize most of the residual proteins.  
Neither additional bands nor changes in band intensity could be detected in Coomassie 
stained gels when extracts from wildtype and mutant mice were compared (Fig. 3-11). 
The extracts were also blotted onto nitrocellulose membranes and analysed with specific 
antibodies against all matrilins. Matrilin-3 was solubilized in high salt/EDTA containing 
buffer in wildtype mice while matrilin-3 proteins were absent in null mice (Fig. 3-12). 
Matrilin-1 and matrilin-4 were also mainly extracted with high salt/EDTA containing 
buffers, both in wildtype and matrilin-3 deficient mice. In contrast, matrilin-2 was 
obtained already in TBS, indicating that matrilin-2 is more weakly bound than other 
matrilins. Nevertheless, no differences could be detected between wildtype and mutant 
mice (Fig. 3-12).  
It has been demonstrated that COMP (cartilage oligomeric matrix protein) (Mann et al., 
2004) and collagen type II (Winterbottom et al., 1992) bind to matrilins. To address the 
question of whether lack of matrilin-3 influences the stability and solubility of those 
binding partners, immunostaining of knee and sternal extracts were performed using 
specific antibodies against COMP and collagen type II. A small portion of COMP was 
solubilized in TBS, however, most protein was extracted by high salt/EDTA 
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 containing buffers. In contrast, most collagen type II was extracted in GuHCl. The same 
was observed in matrilin-3 null mice (Fig. 3-12). 
Taken together, neither expression nor solubility of matrilin-1, -2, –4, COMP or 
collagen type II were altered in mice lacking matrilin-3. 
 
 
Fig. 3-11 Biochemical analysis of wildtype (wt) and mutant (mt) knee joint and sternal cartilages. 
Coomassie-stained SDS-polyacrylamide gel (4-15%) of proteins sequentially extracted with buffer1 
(TBS), buffer 2 (high salt/EDTA), and buffer 3 (GuHCl) (see Materials and Methods) from newborn knee 
joint and sternal cartilage.  
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Fig. 3-12 Western blot analysis of proteins sequentially extracted with buffer 1 (TBS), buffer 2 (high 
salt/EDTA), and buffer 3 (GuHCl) from wildtype (wt) and mutant (ko) knee joint and sternal of newborn 
mice. Proteins were immunostained with specific antibodies against matrilin-1 (matn1), matrilin-2 
(matn2), matrilin-3 (matn3), and matrilin-4 (matn4) and for COMP and collagen II (col2). 
 
Proteoglycans are one of the major constituents of the extracellular matrix and it has 
been shown that matrilin-1 binds to aggrecan, the most abundant proteoglycan in 
cartilage (Hauser et al., 1996). In addition, matrilins were shown to bind to the small 
leucine-rich repeat proteoglycans decorin and biglycan (Wiberg et al., 2003). Since 
matrilin-1 and matrilin-3 have the same tissue distribution pattern, the proteoglycan 
content was determined in cartilage from the matrilin-3 deficient mice. 
Proteoglycans are complex macromolecules consisting of a protein core with one or 
more covalently attached glycosaminoglycan (GAG) chains. The dimethylmethylene 
blue assay for sulphated glycosaminoglycans has found wide acceptance as a quick and 
simple method of measuring the sulphated glycosaminoglycan content of tissue and 
fluids. (Enobakhare et al., 1996).  
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 The glycosaminoglycan contents were analysed in single knee and sternal extracts (Fig. 
3-13). Three independent experiments were done under slightly different conditions. 
There was no significant difference in the contents of sulphated glycosaminoglycans 
between wildtype and matrilin-3 mutant mice.  
 
 
Fig. 3-13 GAG assay of knee and sternum cartilage extracts derived from 4-weeks-old wildtype (wt) and 
matrilin-3 knockout (ko) mice with buffer 1 (TBS), buffer 2 (high salt/EDTA) and buffer 3 (GuHCl).  
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 3.1.6. Summary 
In summary, our results show that the absence of matrilin-3 in mice does not have an 
impact on endochondral bone formation. Therefore it is unlikely that loss-of-function 
mutations in the matrilin-3 gene account for MED and MED-like disorders seen in 
humans. Generation of multiple-knockout mice or mice carrying dominant-negative 
mutations might be necessary to clarify the function of matrilins in skeletal 
development and the etiology of chondrodysplasias, respectively.  
Matrilin-1 null mice have been generated earlier (Aszodi et al., 1999) and breeding to 
create matrilin-1and matrilin-3 double deficient mice was therefore the next logical step 
to elucidate matrilin function in skeletal development. 
3.2. Matrilin-1/matrilin-3 double deficient mice 
Matrilin-1/ matrilin-3 double deficient mice were obtained by crossing the single 
deficient mice. Detailed histological assessments were performed as for matrilin-3 
single null mice (collaboration with Dr. A. Aszodi, Munich). However, the double null 
mice did not show any obvious abnormalities, were fertile and had normal life spans. 
To determine whether the apparent lack of an skeletal phenotype in the Matn-1/-3 null 
mice is due to compensation by structurally or functionally related proteins, the tissue 
contents of other members of the matrilin family as well as of known matrilin binding 
partners were analyzed. 
As performed earlier for the matrilin-3 single knockout mice, proteins were extracted 
from sternum and knee cartilage with buffer 1 (TBS), buffer 2 (high salt/EDTA), and 
buffer 3 (GuHCl). The reproducibility of the extraction was checked on Coomassie 
stained SDS-polyacrylamide gels (not shown). The amounts of matrilin-1, -2, -3 and -4, 
COMP, collagen type II, biglycan and decorin were examined by immunoblotting after 
nonreducing SDS-polyacrylamide gel electrophoresis. In initial analyses it was shown 
that there were no obvious differences between homozygous and double heterozygous 
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 wildtype mice or single homozygous and heterozygous single mutants (not shown). To 
detect potential quantitative effects of allele-loss, the double heterozygous wildtype 
animals were compared with the double mutant mice and single matrilin-1 or -3 mutant 
mice that lacked also one additional allele of matrilin-1 or -3. Cartilage from newborn 
double knockout mice contained matrilin-2 and matrilin-4 (Fig. 3-14). The amounts of 
matrilin-2 in mutant cartilages were similar to those of the control (Fig. 3-14) whereas 
matrilin-4 gave significantly stronger signals in high salt/EDTA and GuHCl extracts of 
cartilages from knees of newborn mice. This result was confirmed in three independent 
extraction experiments (Fig. 3-15). Sternal cartilages showed a less pronounced increase 
in matrilin-4 both in newborn (Fig. 3-14) and in 4.5-week old mice (not shown). 
Interestingly, the upregulation of matrilin-4 was seen also in the mice lacking only 
matrilin-1, whereas it was not detected in the matrilin-3 knockout mice (Fig. 3-14). In 
addition, the matrilin-4 band pattern was altered in the matrilin-1 and the matrilin-1/-3 
deficient newborn mice. By double fluorescence staining of immunoblots with 
antibodies specific for matrilin-1 and -4 we could show that a major band (Fig. 3-16 
arrow b) that disappears in the matrilin-1 and the matrilin-1/-3 deficient mice does not 
represent heterooligomers of matrilin-1 and -4, whereas a second much weaker band 
(Fig. 3-16 arrow c) could. This latter band is, however, so close to the strong matrilin-1 
homotrimer band that an overlap cannot be excluded. In vitro experiments with 
recombinant coiled-coil domains have shown the propensity of matrilin-1 and -4 for 
heterooligomer formation (Frank et al., 2002). In addition to the changes in matrilin-4 
expression, also other slight changes could be detected in the single knockouts for 
matrilin-1 and -3. In wildtype mice a minor band (Fig. 3-14, asterisk) was found above 
the main matrilin-1 containing band and the corresponding band was missing in the 
matrilin-3 null mice (Fig. 3-14). As it has the same electrophoretic mobility as a 
matrilin-3 positive band it is likely to represent heterooligomers formed of matrilin-1 
and –3 (Fig. 3-14). Further, in the mice lacking only matrilin-1, the pattern of matrilin-3 
oligomers is clearly altered (Fig. 3-14). In contrast, immunoblot analysis of the matrilin 
interaction partners COMP, collagen type II, biglycan and decorin revealed no apparent 
differences between control and mutant cartilage (Fig. 3-14). 
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Fig. 3-14 Biochemical analysis of wildtype and mutant knee joint cartilages. Proteins were sequentially 
extracted with buffer 1(TBS), buffer 2 (high salt/EDTA), and buffer 3 (GuHCl) from newborn knee joint 
and sternum cartilage. Western blot analysis was performed for matrilin-1 (Matn1), matrilin-2 (Matn2), 
matrilin-3 (Matn3), matrilin-4 (Matn4), COMP, collagen II (Col2), biglycan (Bgn) and decorin (Dcn). A: 
matn1 +/-, matn3 +/-, B: matn1 -/-, matn3 +/-, C: matn1 +/-, matn3 -/-, D: matn1 -/-, matn3 -/-. Asterisk, 
additional band which is missed in matrilin-3 single knockout mice (C). 
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Fig. 3-15 Changes of matrilin-4 expression in matrilin-1 and matrilin-1/-3 deficient mice. Protein extracts 
obtained with buffer 2 (high salt/EDTA) from knee cartilage of three different mice (I, II and III) from 
each group of newborn mice (A, B, C and D as in Fig. 3-14) were submitted to immunoblot analysis 
using matrilin-4 specific antibodies. 
 
 
Fig. 3-16 Changes of matrilin-4 expression in matrilin-1 and matrilin-1/-3 deficient mice. Infrared 
fluorograph of an immunoblot of knee cartilage extracted with buffers 1 (TBS), buffer 2 (high salt/EDTA) 
and buffer 3 (GuHCl). A, B, C and D as in Fig. 3-14. Green, matrilin-1 homotrimer; Red, matrilin-4. a, 
matrilin-4 trimer; b, major band; c, minor band; d, matrilin-4 dimer. 
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 3.2.1. Summary 
Although mice lacking either matrilin-1 (Aszodi et al., 1999) or matrilin-3 did not show 
apparent abnormalities by histological and immunostaining analyses, biochemical 
analyses revealed a molecular phenotype in matrilin-1/-3 double null mice in which the 
amount of matrilin-4 protein is increased and the band pattern of matrilin-3 and -4 is 
altered. The upregulation of matrilin-4 is likely to represent a compensatory mechanism. 
Inactivation of the matrilin-4 gene, in addition to matrilin-1 and –3, may yield further 
information on matrilin function.  
In the process of evolution, genes become more diverse and protein expression is 
regulated in a more complex manner. Therefore, elucidation of the function of a certain 
gene or protein is particularly difficult in higher organisms. A simple vertebrate model 
organism may give a better insight into the function of matrilins. The zebrafish (Danio 
rerio) is a powerful model organism for the study vertebrate development and was 
chosen as an alternative system in which to investigate matrilin function. 
3.3. Matrilins in zebrafish 
The zebrafish (Danio rerio) is a well established model organism. The embryos develop 
rapidly, with all organs having been formed by 72 hpf (hours post fertilization). The 
externally developing embryos are optically clear and are produced in large numbers, 
therefore large-scale mutagenesis programs can be monitored by simple microscopic 
observation of the embryos (Haffter et al., 1996). The genome sequencing project has 
been completed to 60% and is expected to be finished by the end of 2005. For this part 
of the dissertation, a fish facility was set up with the long-term goal of using the 
zebrafish to study matrilin function. The structure and genetic organization of matrilins 
in zebrafish has been characterized (Ko et al., 2005). My experiments focused on the 
investigation of matrilin expression in zebrafish and on functional analyses by a 
morpholino knockdown approach. 
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 3.3.1. Generation of zebrafish-matrilin-specific antisera 
Specific antibodies against each zebrafish matrilin family member were generated in 
order to study their temporal and spatial expression.  
cDNAs encoding the sequences of zebrafish matrilin VWA1 domains of matrilin-1, -3a, 
-3b and -4 were cloned into the pCEP-Pu vector utilizing the BM-40 secretion signal 
sequence and an N-terminal His6-tag (Smyth et al., 2000). The recombinant plasmids 
were introduced into HEK-293/EBNA cells and maintained in an episomal form. The 
recombinant proteins secreted into the cell culture medium were, except for matrilin-3b, 
subsequently purified by affinity chromatography on a cobalt column. The purified 
proteins appeared in non-reducing SDS-PAGE mainly as monomeric molecules, but 
small amounts of higher oligomers could also be detected (Fig. 3-17). After reduction 
single bands with apparent molecular masses in the range expected for monomeric 
VWA domains were seen (results not shown). The purified proteins (Fig. 3-17) were 
used to immunize rabbits.  
 
Fig. 3-17 Purity of recombinant VWA1 domains. Affinity purified VWA1 domains proteins of matrilin-1 
(matn1), matrilin-3a (matn3a), matrilin-3b (matn3b) and matrilin-4 (matn4) were checked on 12% 
non-reducing SDS-polyacrylamide gel. Matrilin-1, -3b and –4 VWA1 domains were mainly present as 
monomers, whereas matrilin-3a occurred both as monomers and dimers. 
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 The antisera obtained were first tested for specificity by ELISA analysis. The results 
showed that the antisera against matrilin-1 had negligible cross reactivity to matrilin-3a 
and –4 recombinant proteins (Fig. 3-18). However, antibodies against matrilin-3a 
and –4 had strong cross reactivities to matrilin-1/-4 and matrilin-1/-3a proteins, 
respectively (Fig. 3-18). After further purification by affinity chromatography on 
columns carrying the original antigens, the antibodies were shown by ELISA to be 
highly specific for the matrilin form used for immunization (Fig. 3-19). 
 
 
Fig. 3-18 Cross-reactivity of crude sera against matrilin-1 (A), matrilin-3a (B) and matrilin-4 (C) with 
VWA1 proteins. (A) Crude serum against matrilin-1 showed high affinity to matrilin-1 with minor 
cross-reactivities to matrilin-3a (3za1) and matrilin-4 (4za1) VWA1 proteins. Crude sera against 
matrilin-3a (B) and matrilin-4 (C) have strong cross-reactivities to matrilin-1 (1za1), 3za1 and 1za1/ 3za1, 
respectively. 
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Fig. 3-19 Cross reactivity of affinity purified antibodies. After purification by affinity chromatography on 
a column carrying the original antigen, the antibody against matrilin-1 (A) and matrilin-3a VWA domains 
(B) showed no remaining cross-reactivity to recombinant VWA1 domains of matrilin-3a (3za1), 
matrilin-4 (4za1) and matrilin-1 (1za1) and 4za1, respectively. (C) The affinity purified antibody against 
matrilin-4 showed a minor cross-reactivities with matrilin-3 (3za1) and –1 (1za1). 
 
As the discovery of matrilin-3b was only recent, an antiserum to this protein is still 
underway. Hence, the cross-reactivity of each of the matrilin-1, -3a and -4 antibodies to 
the matrilin-3b protein was first examined. The antibody to matrilin-3a showed only a 
marginal cross-reactivity with the matrilin-3b VWA1 domain (Fig. 3-20 and Fig. 3-21), 
despite their high sequence identity. Surprisingly, matrilin-1 had strong cross-reactivity 
to matrilin-3b and the cross-reaction was still present after depletion on a 
chromatography column carrying recombinant matrilin-3b protein (Fig. 3-21). After 
reiterating the depletion procedure, the anti-matrilin-1 titer was lost (data not shown). 
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 Cross-reactivity via His6 epitope could be ruled out (not shown) and the results indicate 
that matrilin-1 and matrilin-3b share a common epitope. Fortunately, preincubation of 
matrilin-1 antibody with matrilin-3b recombinant protein before applying it in the 
ELISA assay could inhibit this cross-reactivity (Fig. 3-22 B) without loss of affinity to 
matrilin-1 protein (Fig. 3-22 A). 
 
Fig. 3-20 Cross-reactivity of the antibody to matrilin-3a with matrilin-3b. (A) Immunoblot analysis of cell 
culture supernatant of non-transfected (nt) and matrilin-3b VWA domain-expressing (3b) 
HEK-293/EBNA cells and purified matrilin-3a VWA domain at different concentrations (3a) using the 
antibody specific for matrilin-3a. (B) Ponceau staining of (A) to show protein 
loading.
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Fig. 3-21 Cross-reactivities of affinity purified antibodies against matrilin-1 (A), matrilin-3a (B) and 
matrilin-4 (C) VWA domains with matrilin-3b recombinant VWA domain (3bza1). The antibody against 
matrilin-1 has a strong cross-reactivity to 3bza1 protein (A), whereas the antibodies against matrilin-3a (B) 
and matrilin-4 (C) do not. 
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Fig. 3-22 ELISA after blocking the matrilin-1 antibody with matrilin-3b protein. The antibody against 
matrilin-1 retains high titer to the matrilin-1 VWA1 domain after preincubation with matrilin-3b VWA 
domain (A), while the titer to matrilin-3b was markedly decreased (B). 
3.3.2. Matrilin expression during development 
The differential expression of the four zebrafish matrilin genes was studied by RT-PCR 
at 24, 48, and 72 hpf as well as in adult fish (Fig. 3-23). At 24 hpf, matrilin-4 is already 
clearly expressed, whereas PCR products corresponding to matrilin-3a and -3b were 
weak and matrilin-1 could be detected only after overexposure (not shown). At 48 hpf 
matrilin-4 is strongly expressed and matrilin-3a and -3b are clearly present, again 
matrilin-1 could hardly be detected. All matrilins show the highest expression at 72 hpf. 
In adult fish, mRNAs for matrilin-1, -3a and -4 are clearly present, whereas for 
matrilin-3b only the shortest splice variant containing the VWA domain and the coiled- 
coil domain could be detected as a weak band. The splice variants carrying the proline- 
and threonine/serine-rich stretch of amino acid residues were not found in adult fish. 
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Fig. 3-23 RT-PCR analysis of matrilin mRNA species expressed during zebrafish development. RT-PCR 
analysis was performed at 24, 48 and 72 hpf, as well as in adult fish using primer pair m1z3 and m1z4 for 
matrilin-1, m3az3 and m3az4 for matrilin-3a, m3bz2 and m3bz4 for matrilin-3b, and m4z1 and m4z4 for 
matrilin-4 (see Materials and Methods). The 1-kb ladder from Gibco-BRL was used as a marker. Bands 
marked with asterisks have been shown by sequencing to be artefactual. In the control sample water was 
included instead of an cDNA solution. matn, matrilin. Arrows mark the bands coding for matrilin-3b 
spice variants carrying the proline and threonine/serine-rich domain. 
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 3.3.3. Matrilins are differentially expressed 
Whole mount immunostaining was performed on 4-day-old fish using the 
affinity-purified matrilin antibodies (Fig. 3-24 F–L). All matrilins are present in the 
developing skeleton. The matrilin-3a antibody strongly stained Meckel’s cartilage, the 
palatoquadrate, the ceratohyal, the ethmoid plate, the anterior basicranial commissure, 
the parachordal, the hyosymplectic and the auditory capsule, as well as the basis of the 
pectoral fin (Fig. 3-24 G and K). In addition, matrilin-1 was found in the posterior part 
of the notochord (Fig. 3-24 I). In contrast to matrilin-1 and -3a, matrilin-4 showed 
similar staining intensity in Meckel’s cartilage, the ceratohyal and the five 
ceratobranchials (Fig. 3-24 H and L). Further, the matrilin-4 antibody stained the eye 
(Fig. 3-24 H and L), the skin (Fig. 3-24 H and L) and the myosepta (Fig. 3-24 L). In all 
fins matrilin-4 staining could be detected in the fin rays (Fig. 3-24 L).  
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Fig. 3-24  Matrilin tissue distribution in zebrafish larvae. (A-C) Immunostaining of sectioned 5 dpf 
zebrafish larvae heads and trunks. Paraffin-embedded sections were incubated with affinity-purified 
antibodies against matrilin-1 (A), -3a (B) or -4 (C), followed by biotin–streptavidin–peroxidase- 
conjugated goat anti-mouse IgG and alkaline phosphatase-conjugated streptavidin. Matrilin-1 (A), -3a (B) 
and -4 (C) were expressed throughout the skeletal tissues, including orbital cartilage (oc), Meckel’s 
cartilage (m), ethmoid plate (e), trabecular cartilage (tc), parachordal cartilage (pc), ceratohyal (ch) and 
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 ceratobranchials (cb) one to five. Matrilin-1 was also found in the notochord (no) and matrilin-4 in 
myoseptum (ms), surrounding the eyes (ey), and in the brain cortex (b). (F–L) Whole mount 
immunostaining of 4 dpf zebrafish larvae. Specimens were incubated with affinity-purified antibodies 
against matrilin-1 (F, I), -3a (G, K) or -4 (H, L), followed by biotin–streptavidin–peroxidase-conjugated 
goat anti-mouse IgG and alkaline phosphatase-conjugated streptavidin. Ventral views of the head (F–H) 
and lateral views of whole fish (I–L) are shown. The pharyngeal skeleton is shown schematically 
(Schilling et al., 1996) in lateral (D), and ventral (E) views. Cartilages of the same segment share the 
same color: P1 (mandibular, blue), P2 (hyoid, yellow), P3 (first branchial, pink), P4 (orange), P5 (green), 
P6 (purple) and P7 (black). The neurocranium is shaded uniformly grey. abc, anterior basicranial 
commissure; ac, auditory capsule; bb, basibranchial; bh, basihyal; c, cleithrum; hb, hypobranchial; hs, 
hyosymplectic; ih, interhyal; ot, otic capsule; pq, palatoquadrate; t, trabeculae cranii. Scale bars, 200 um. 
matn, matrilin. 
 
In addition, the tissue distribution of zebrafish matrilins was investigated on paraffin 
sections of 5 dpf and 4-month-old zebrafish. Sectioning of 5 dpf fish (Fig. 3-24 A–C) 
clearly confirmed the restricted skeletal staining of matrilin-3a seen in whole mount 
stainings (Fig. 3-24 K). In contrast, matrilin-1 could be detected in the notochord and in 
intestine, albeit after long exposure (Fig. 3-24 A). Matrilin-4 is more widespread and 
could be detected in the eye and in the myoseptum (Fig. 3-24 C), as well as in skeletal 
tissues. The overall expression pattern was not altered in sections of 4-month-old fish, 
but as the fish were larger a more detailed analysis could be performed (Fig. 3-25). In 
consecutive sections through the trabecular bone of the skull matrilin-1 (Fig. 3-25 G) 
and matrilin-3a (Fig. 3-25 H) showed a similar expression in proliferating, and more 
strongly in hypertrophic cartilage, but only matrilin-3a was found in perichondrium (Fig. 
3-25 H). In contrast, matrilin-4 revealed a strong zonal expression in the proliferating 
cartilage (Fig. 3-25 I). In vertebrae the staining for matrilin-3a was broad and strong 
(Fig. 3-25 L), whereas matrilin-1 and -4 are expressed only around proliferating chon- 
drocytes (Fig. 3-25 K, M). Uniquely, matrilin-1 shows a staining in the notochord and 
in the surrounding secondary chordal sheath (Fig. 3-25 A, B, K), whereas matrilin -3a is 
not present in these tissues (Fig. 3-25 D). Matrilin-1 can still be detected in intestine 
(Fig. 3-25 C) and, as in 5 dpf fish, matrilin-4 was found in myoseptum (Fig. 3-25 F). 
Interestingly, matrilin-4 is strongly expressed in the adenohypophysis (Fig. 3-25 E). 
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Fig. 3-25 Matrilin tissue distribution in 4-month-old zebrafish. (A–F) Immunofluorescence microscopy 
was carried out on paraffin-embedded tissue sections which were incubated with affinity-purified 
antibodies against matrilin-1 (A–C), -3a (D) or -4 (E, F), followed by Cy3-conjugated goat anti-rabbit 
IgG. In the vertebrae (vb), matrilin-1 was detected in the cartilage, in the secondary chordal sheath (sc) 
(A), the notochord (no) network (B) and in the intestinal epithelium (ep) (C), whereas matrilin-3a was 
found in the cartilage of the vertebrae (vb) (D). Strong signals for matrilin-4 were found in the 
adenohypophysis (ad) (E) and in myosepta (ms) (F) throughout the fish. (G–M) Immunohistochemistry 
was performed on paraffin-embedded tissue sections by staining with affinity-purified antibodies against 
matrilin-1 (G, K), -3a (H, L) or –4 (I, M) followed by biotin–streptavidin–peroxidase-conjugated goat 
anti-mouse IgG and alkaline phosphatase-conjugated streptavidin. In the trabecular bone (G–I) and 
vertebrae (K–M), matrilin-1 is deposited in proliferating (pc) and hypertrophic cartilage (hc) and in the 
secondary chordal sheath (sc) (G, K); matrilin-3a is expressed throughout the cartilage including 
proliferating (pc) and hypertrophic cartilage (hc) (H, L) and perichondrium (pe) (H); whereas matrilin-4 is 
weakly expressed only in the proliferating cartilage (pc) (I, M). te, tendon. Scale bars represent 100 um, 
except for those in (B, E) which represent 50 um. matn, matrilin. 
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 3.3.4. Morpholino knockdowns of matrilins 
3.3.4.1. Specificity of morpholinos 
In this project, morpholino antisense oligonucleotides were employed to investigate 
matrilin function in zebrafish. Since the morpholinos we used function by covering the 
AUG translational starting site, which in turn inhibits translation, the downregulation of 
protein would be important evidence to prove whether the morpholinos really function. 
0.5 nl morpholino solution (0.5 mM) directed against matrilin-4 was microinjected into 
one-cell embryo yolk sacs and whole mount immunostaining of 24 hpf embryos with a 
specific antibody against matrilin-4 revealed a decreased matrilin-4 protein content in 
myosepta (Fig. 3-26). At a higher dose (2 nl), signals in myosepta disappear and in 
addition, a curled body shape and poorly developed eyes were observed. A morpholino 
which does not bind to any gene was used as negative control and showed the same 
matrilin-4 protein amount as in non-injected wildtype embryos (Fig. 3-26). These 
results demonstrate that the morpholino is functional and the knockdown effect is 
specific. 
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Fig. 3-26 Protein loss in matrilin-4 morpholino knockdown embryos at 24 hpf. (A) Whole mount 
immunostainings were performed in embryos of non-injected wildtype (wt), (B) embryo injected with 2 
nl of 0.5 mM negative control morpholino (Neg) and 0.5 nl (C) and 2 nl (D) of 0.5 mM morpholino 
against matrilin-4 (matn4) at 24hpf. In wildtype embryos and embryos injected with negative control 
morpholino (Neg), matrilin-4 was stained in myosepta and eyes (ey) (A , B), whereas in embryos injected 
with 0.5 nl morpholino against matrilin-4 (C), expression of matrilin-4 in myoseptum disappeared even 
though the embryos did not show any apparent abnormality in body shape and immunostaining could still 
be seen in the eyes (C). In matrilin-4 knockdown embryos injected with a higher morpholino dose (2 nl), 
abnormalities in body shape occurred together with a poor eye development (D). Immunostaining with 
specific antibody against matrilin-4 revealed a decreased signal in eyes, while myosepta were truncated 
and the notochord bent.  
3.3.4.2. Matrilin knockdown phenotypes 
In the morpholino knockdown experiments, chordin, an antagonist of bone 
morphogenetic protein, is often used as a positive control. The knockdown phenotypes 
of chordin have been well characterized showing abnormal u-shaped somites, abnormal 
tail fin, smaller head and expanded blood island (Nasevicius and Ekker, 2000). 
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 Observation of the same phenotypes (Fig. 3-27) indicates a specific knockdown effect 
of morpholino and thereby technically successful microinjection. 
The phenotypes seen in matrilin-1, -3a and -4 knockdown embryos are shown in Fig. 
3-27. Upon injecting anti-matrilin-1 morpholinos, we observed an u-shaped body with 
an abnormal caudal fin (Fig. 3-27). Zebrafish injected with matrilin-3a morpholinos also 
present small body size and a malformed caudal fin (Fig. 3-27), while injection of 
matrilin-4 morpholinos yields a truncated caudal region (Fig. 3-27) and a lower survival 
rate (not shown). This may indicate that loss of the matrilin-4 gene has a stronger effect 
on early development due to earlier or broader expression. Matrilin-3b had not yet been 
identified at the time of these experiments and its knockdown phenotype remains to be 
studied. 
Skeletal malformations occur in all matrilin knockdown embryos, indicating that 
matrilins play important roles during zebrafish skeletal development. However, within 
the scope of this work, it was only possible to investigate one member of the matrilin 
family in detail.  
Since matrilin-1 is the most abundant matrilin and had been most extensively 
characterized in mammals and birds, matrilin-1 was chosen for in depth study. 
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Fig. 3-27 Phenotypes of matrilin knockdown embryos. Chordin knockdown embryos showed a smaller 
head, an enlarged blood island (BI) and an abnormal caudal fin. Upon injection of matrilin-1 morpholinos 
embryos took on a curled body shape and displayed an abnormal caudal fin. In knockdowns of 
matrilin-3a, the embryos had a smaller head and a bent body axis. The matrilin-4 knockdown embryos 
showed a truncated caudal region and the caudal fin did not develop. 
3.3.4.3. Matrilin-1 knockdown phenotype 
Upon injecting anti-matrilin-1 morpholinos, at 48 hpf we observed a small head and an 
abnormal spinal cord (Fig. 3-28 D and E). When the doses were increased, the body was 
truncated, the heads smaller and the eyes poorly developed (Fig. 3-28 E, arrow). 
Zebrafish injected with nonsense (MO-Neg) or 5-mismatch matrilin-1 morpholino 
(5m-m1) did not present any obvious abnormalities (Fig. 3-28 B and C). A closer view 
of matrilin-1 knockdown embryos at 48 hpf showed that some have not developed the 
notochord and the pectoral fin (Fig. 3-29 A-C), but also that some embryos appear more 
normal (Fig. 3-29 D-F), even though these fish still have a curled body shape. 
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Fig. 3-28 Phenotypes of matrilin-1 knockdown embryos at 48 hpf. Overview of embryos without any 
injection (wt, A), injected with negative control morpholinos (Neg, B), 5-mismatch of matrilin-1 
morpholino (5m-m1, C) and matrilin-1 morpholino (Mo-m1, D and E). Neither injection of 5-mismatch 
matrilin-1 (C) nor standard control morpholino cause abnormalities (B). However, matrilin-1 knockdown 
embryos had a curled body shape and a slightly smaller head (D, 2 nl). In higher doses (2.87 nl), the body 
axis did not longer develop (E, red arrow). Scale bar: A, Band C, 1180 um ; D and E, 800 um. 
 
Fig. 3-29 Matrilin-1 knockdown phenotype. Matrilin-1 knockdown embryos at 48 hpf showed a curled 
body shape (A, D). Some of them had normal notochord (no) and pectoral fin (pf) development (D, E, F) 
but some did not (A, B, C). B and C are higher magnifications of A, and E and F of D. 
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 To examine whether skeletal architecture was altered, whole mount alcian blue staining 
for cartilage of wildtype and matrilin-1 knockdown embryos was performed at 48 hpf 
(Fig. 3-30). The overall size of the head was smaller and shorter in matrilin-1 
knockdown embryos (Fig. 3-30 D), but the reduction was not so pronounced that it 
could be seen in anesthetized live embryos (Fig. 3-30 B). Alcian blue staining also 
showed a shorter ethmoid plate and the lack of the fifth ceratobranchial (Fig. 3-30 D). 
Meckel’s cartilage did not protrude as it does in wildtype (Fig. 3-30 D). In addition, the 
optic capsules were not stained in matrilin-1 knockdown embryos (not shown). In live 
embryos, it was seen that injection of matrilin-1 morpholino caused a retarded eye 
development as compared to that of wildtype (Fig. 3-30 B and D).  
 
Fig. 3-30 Skeletal phenotype of matrilin-1 knockdown embryo. Matrilin-1 knockdown (matn1, B) 
embryos were observed at 48 hpf and showed a curled body shape and smaller eyes compared to that of 
wildtype (wt, A). A ventral view of alcian blue stained cartilages showed that matrilin-1 knockdown 
embryos (D) have smaller heads, shorter ethmoid plates and lack the fifth ceratobranchial (cb). Meckel’s 
cartilage (m) also does not protrude as it does in wildtype embryos (C). Scale bar, A and B, 400 um; C 
and D, 200 um. 
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 3.3.4.4. First characterization of matrilin-3a and matrilin-4 
knockdown embryos 
Matrilin-3a and –4 knockdown embryo phenotypes are shown in Fig. 3-31. Upon 
injection of matrilin-3a morpholinos, embryos showed a curled body axis (Fig. 3-31 
A-C). Injection of matrilin-4 morpholino caused abnormal caudal fins and a shorter 
body axis (Fig. 3-31 D and E) sometimes smaller eyes (Fig. 3-31 F).  
 
 
Fig. 3-31 Phenotypes of matrilin-3a (A-C) and matrilin-4 (D-F) knockdown embryos at 48 hpf. 
3.3.4.5. Phenotype frequency and survival rate 
It is obvious that not all morpholino injected embryos present abnormalities. This 
variation may be due to the efficiency of delivery of the morpholino from the yolk sac 
to the animal pole depending on the position of injection. Therefore it is important to 
calculate the phenotype frequency in order to judge the statistic significance. 
The survival rate was first calculated. A nonsense morpholino and a morpholino 
directed against chordin were used as a negative and a positive control, respectively. 
The survival rate of embryos injected with the anti-matrilin-1 morpholino was the same 
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 as that of controls. 40% of matrilin-1 knockdown embryos survive at 24 hpf and only 
half of them can survive for further 24 h. Therefore the phenotype frequency was 
calculated at 48 hpf.  
About 10% of embryos injected with negative control morpholino showed an abnormal 
phenotype, whereas 60% of embryos injected with the anti-chordin morpholino showed 
a phenotype. Embryos injected with the anti-matrilin-1 morpholino revealed a 55% 
phenotype frequency.   
 
  
Fig. 3-32 Survival rate and phenotype frequency of morpholino knockdown embryos. Survival rates were 
measured at 24, 48 and 72 hpf for embryos injected with negative control, chordin and matrilin-1 (matn1z) 
morpholino. The phenotype frequency was calculated at 48 hpf. 
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 4. Discussion                       
4.1. Mouse matrilins 
It has been proposed that matrilins play an important structural role in extracellular 
matrices by being part of filamentous networks. In cartilage, all four members of the 
matrilin family are expressed, suggesting important biological role(s) for matrilins in 
this tissue. Studies with chondrosarcoma cell lines or with primary chondrocytes 
revealed that matrilin-3/matrilin-1 networks connect neighboring cells in a 
collagen-dependent manner, whereas in the pericellular matrix, these matrilins also 
form collagen-independent filaments (Chen et al., 1995; Chen et al., 1999; Klatt et al., 
2000). Matrilin-1, the best-characterized matrilin, binds with a certain periodicity to 
type II collagen fibrils (Winterbottom et al., 1992) and becomes covalently attached to 
aggrecan (Hauser et al., 1996), presumably forming a bridge between the two major 
supramolecular components of the cartilage. Based on structural similarities, this 
bridging, or adaptor function was suggested as a common feature of all matrilins (Deak 
et al., 1999). A study in the Swarm rat chondrosarcoma indicates that the actual 
interactions between matrilins and other cartilage matrix proteins might be even more 
complex. It was shown that matrilin-1, matrilin-3, and matrilin-4 form complexes with 
the small leucine-rich repeat (LRR) proteoglycans decorin and biglycan, which in turn 
bind to the N terminal VWA domains of collagen type VI. In this manner matrilins and 
LRR proteoglycans may together link collagen VI microfibrils to aggrecan or collagen 
II (Wiberg et al., 2003).  
The biological relevance of such matrilin-mediated interactions is not clear. 
Matrilin-1-deficient mice have no obvious skeletal defects (Aszodi et al., 1999; Huang 
et al., 1999), and in this dissertation it is shown that mice lacking matrilin-3 are 
indistinguishable from wildtype mice and display normal cartilage and bone 
development. There are also no alternations in the deposition of cartilage matrix 
proteins, such as collagen II and aggrecan, in chondrocyte differentiation, growth plate 
structure, and replacement of cartilage by bone. In contrast to Matn-1 null mice, 
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 where one of the two strains produced show a mild defect in collagen fibril organization 
in the maturation and hypertrophic zone of the growth plate (Aszodi et al., 1999; Huang 
et al., 1999), no ultrastructural abnormalities were observed in Matn-3-deficient mice. 
These results suggest that the absence of matrilin-3 alone has no influence on skeletal 
development and the proper assembly of the extracellular matrix. 
4.1.1. Matrilin-3 is dispensable for mouse skeletal 
development 
The lack of an apparent phenotype in matrilin-3 null cartilage could be explained by a 
functional compensation by other members of the matrilin family expressed in skeletal 
tissues. Matrilin-3 is coexpressed with matrilin-1 and matrilin-4 in the resting, 
proliferative, and hypertrophic zones of the developing knee joint, and all four matrilins 
are present in the proliferative and upper hypertrophic zones (Klatt et al., 2002) (Fig. 
3-9). Similarly, matrilin-3 is coexpressed with at least one other matrilin in the articular, 
sternal, costal, and vertebral cartilage and the inner part of the annulus fibrosus of the 
intervertebral disk (Klatt et al., 2002). Northern blot, immunohistochemical, and 
biochemical analyses of newborn knee joint or sternal cartilage did not reveal a 
compensatory upregulation of Matn-1, Matn-2 or Matn-4 in Matn-3 null mice, but 
redundancy between matrilin-3 and, especially, matrilin-1 and/or matrilin-4 cannot be 
excluded. Such a redundancy among matrilins was already suggested to explain the lack 
of an overt phenotype in the matrilin-1-deficient mice (Aszodi et al., 1999; Huang et al., 
1999). 
4.1.2. A biochemical phenotype in matrilin-1/matrilin-3 
double deficient mice 
Despite the lack of perceptible changes from biochemical analysis of single matrilin 
knockout mice (Aszodi et al. 1999; Huang et al, 1999; Ko et al., 2004, Mates et al., 
2004), in this dissertation an increased amount of matrilin-4 was found in cartilage 
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 extracts of newborn matrilin-1/matrilin-3 double knockout mice as compared to 
wildtype mice. Reexamination of the matrilin-1 single knockout mice showed an 
upregulation of matrilin-4 also in these animals, a feature missed in the original 
examination of the matrilin-1 knockout (Aszodi et al., 1999) as matrilin-4 antibodies 
were not yet available at that time. As the northern blot shows no upregulation of 
matrilin-4 at the transcriptional level, either translation is increased, the turnover 
decreased or the extractability of matrilin-4 increased. As the matrilins act as adaptor 
proteins, it could be that the loss of another member of the family leads to a less stable 
supramolecular assembly. Further evidence for a close association of matrilin-1 and -4 
comes from the loss of a particular matrilin-4 containing oligomer in both matrilin-1 
and matrilin-1/-3 deficient animals (Fig. 3-16). It was excluded that this band represents 
heterooligomers of matrilin-1 and –4. Based on the electrophoretic mobility the 
molecular mass lies between that of a full-length matrilin-4 trimer and that of a 
proteolytically cleaved dimer (Klatt et al., 2001), which could be due to the occurrence 
of shorter splice variants or N- terminally processed forms of matrilin-4. However, it 
remains unclear why these forms of matrilin-4 are lost in the mice lacking matrilin-1. In 
contrast, the extractability of COMP, collagen type II, biglycan and decorin, which have 
been described as binding partners of matrilins, was not affected. 
4.1.3. Matrilins in disease 
Mutations in extracellular matrix proteins expressed in cartilage frequently lead to 
human osteochondrodysplasias of varying severity. To date, matrilin-3 is the only 
known member of the matrilin family found to be associated with such disorders 
(Chapman et al., 2001). In addition, in a genomic screen of the Icelandic population a 
mutation in the first EGF domain of matrilin-3 was linked to the occurrence of hand 
osteoarthritis (Stefansson et al., 2003). A mild form of the autosomal dominant multiple 
epiphyseal dysplasia (MED) is caused by missense mutations in the second exon of the 
MATN3 gene encoding the VWA domain (Chapman et al., 2001; Mabuchi et al., 2004). 
Another missense mutation in the same region of MATN3 (A128P) was discovered in a 
family with bilateral hereditary microepiphyseal dysplasia (BHMED), which gives a 
skeletal phenotype similar to but still distinct from common MED (Mostert et al., 2003). 
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 In addition, an autosomal recessive form of another osteochondrodysplasia, 
spondylo-epi-metaphyseal dysplasia (SEMD), is caused by a change of a cysteine into a 
serine residue in the first EGF domain of matrilin-3 (Borochowitz et al., 2004), which 
could lead to a disturbance in the disulphide bond formation. These mutations were 
suggested to alter the folding and/or function of the protein, indicating that the disorder 
is most probably due to a dominant-negative effect rather than being caused by 
haploinsufficiency (Briggs and Chapman, 2002; Chapman et al., 2001). This hypothesis 
is further strengthened by the observation that a single nucleotide deletion in MATN3, 
which creates a premature stop codon at amino acid residue 164, has no 
pathophysiological consequence (Briggs and Chapman, 2002). Indeed, the influence of 
the matrilin-3 mutations causing MED, SEMD and hand osteoarthritis on the secretion 
of matrilin-3 was recently studied. The results revealed that matrilin-3 with the 
mutations causing MED and SEMD is retained in the endoplasmic reticulum whereas 
matrilin-3 carrying the hand osteoarthritis mutation could be secreted by chondrocytes 
at a similar rate as wildtype matrilin-3 (Otten et al., 2005). It is likely that this retention 
causes a chondrocyte dysfunction by which MED and SMED phenotypes could be 
explained. 
A similar contrast between the null mutation in mice and the human disorder was 
recently described for COMP. COMP-deficient mice are normal and display no 
detectable skeletal defects (Svensson et al., 2002). Mutations in the human COMP gene, 
however, lead to MED and the clinically more severe pseudoachondroplasia (PSACH) 
(Briggs and Chapman, 2002). Most of these mutations cause conformational changes of 
COMP, resulting in its reduced secretion and accumulation in the rough endoplasmatic 
reticulum. The misfolded COMP molecules, in turn, coretain their physiological 
matrilin partners, including collagen type IX, decorin, and aggrecan, in the rough 
endoplasmatic reticulum, leading to an accumulation of intracellular protein and, as a 
consequence, reduced cell viability (Dinser et al., 2002). 
The lack of a chondrodysplasia phenotype in the matrilin-3-deficient mice is in line with 
these results and strongly points to dominant-negative effects as the pathomechanism of 
MED. 
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 In summary, the results show that the absence of matrilin-3 in mice has no impact on 
endochondral bone formation and indicates that loss-of-function mutation(s) in the 
matrilin-3 gene cannot account for MED and MED-like disorders seen in humans. The 
lack of obvious phenotypes even in matrilin double knockout mice will make the 
analysis of matrilin function by the knockout technology complicated and laborious as 
probably only triple or even quadruple knockouts will show an effect. Therefore an 
alternative animal model, which possibly displays a lesser redundancy would be 
desirable. 
4.2. Zebrafish matrilins 
The zebrafish is a powerful model organism for the study of vertebrate development. 
The rapid embryonal development, the transparency of embryos and the high fertility 
leading to large numbers of embryos allows large-scale mutagenesis in a fast and easy 
way. As matrilins are not found in invertebrates as Drosophila or C. elegans, zebrafish 
is among the simplest organisms, which express matrilins. The presence of highly 
conserved zebrafish orthologues points to an important biological function of this gene 
family.  
Therefore zebrafish was chosen as a second model organism in which to study matrilin 
function. In contrast to mouse, only three members of the matrilin family can be found 
in zebrafish, matrilin-1, -3 and –4, even though the matrilin-3 gene has been duplicated 
(Ko et al., 2004). A matrilin-2 gene could not be identified in zebrafish by screening the 
draft sequence of the zebrafish genome project, which is finished to 60%, or by 
performing RT-PCR using degenerate primers (Ko et al., 2004). The temporal and 
spatial expression patterns of zebrafish matrilins are characterized in this dissertation 
and show similarities to those of their mouse orthologues (Klatt et al., 2002).  
Matrilin-1 can be clearly detected in zebrafish embryos at 72 hpf by RT-PCR and the 
protein is expressed not only in cartilage but also in notochord, secondary chordal 
sheath and intestine. Similar to in mammals (Mundlos and Zabel, 1994), matrilin-1 can 
also be detected in the eyes of adult fish (data not shown). In addition, in situ 
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 hybridization with probes specific for matrilin-1 gives a strong signal in pectoral fins in 
56 hpf embryo (B. Kobbe, pers. communication). The notochord is a source of bone 
matrix and in addition plays a key role in the segmental patterning of vertebrae 
(Fleming et al., 2004), and the expression of matrilin-1 in notochord indicates a role in 
skeletal development.  
Zebrafish matrilin-3a is clearly expressed at 48 hpf. In comparison with the other 
members of the matrilin family, expression of matrilin-3a is more restricted to cartilage. 
Matrilin-3b was identified only recently and a specific antibody was already generated. 
However, due to time limitations, a detailed characterization of matrilin-3b has not yet 
been performed. Nevertheless, RT-PCR results indicate that matrilin-3b is clearly 
expressed, with the earliest detection of mRNA at 24 hpf.  
Similar to its mammalian counterpart (Klatt et al., 2001), zebrafish matrilin-4 is the 
most widely expressed member of the matrilin family. It is also expressed very early in 
development. By RT-PCR a strong signal can be detected already at 24 hpf and protein 
expression is found not only in skeletal tissues but also in myosepta, in tissues 
surrounding the eyes and in the brain cortex. Uniquely, matrilin-4 is strongly expressed 
in the adenohypophysis in adult fish. The expression of matrilin-4 here may indicate a 
function of matrilin-4 in glandular function. Matrilin-4 expression in the 
adenohypophysis of mammals has not yet been studied. 
The large number of splice variants is characteristic for zebrafish matrilins. Nearly all 
splice variants can be detected by RT-PCR at the embryonic stage but not in adult fish. 
It is not clear whether those splice variants have distinct expression patterns or unique 
functions during embryonic development. As specific antibodies were raised against the 
matrilin VWA1 domains which are shared between splice variants, it is not possible to 
answer this question by immunostaining. The alternative splicing of matrilins in 
zebrafish predominately affects the number of EGF-like domains. Even zebrafish 
matrilin-1, -3a and –3b variants occur that completely lack EGF-like domains. 
Therefore, it is very likely that the VWA domains are the principal interaction modules 
of matrilins and that the EGF-like domains act mainly as spacers. 
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 A zebrafish matrilin-3b splice variant contains a sequence rich in proline and 
threonine/serine residues. This sequence is unique among matrilins in all species studied 
and is encoded by a single exon (Ko et al., 2005). Sequences rich in threonine/serine 
residues are often targets for a mucin-type N-acetyl-galactosamine O-glycosylation, and 
if such modification really takes place it may drastically influence the physical 
properties of this matrilin domain and probably evolves a new function. Interestingly, 
the matrilin-3b splice variant containing this new domain is not present in adult fish 
(Fig. 3-23) which may indicate a specific and important function during the 
development. 
In both zebrafish and mammals, matrilins are more highly expressed during 
development than in adults with matrilin-4 showing the earliest onset. All zebrafish 
matrilins are present in cartilage, but their distributions are only partially overlapping 
(Fig. 3-25), which is again reminiscent of the zonal expression of mouse matrilins in the 
growth plate and the articular cartilage (Klatt et al., 2002). 
4.3. Morpholino knockdowns of zebrafish matrilins  
4.3.1. Matrilin knockdown phenotypes 
Specificity is always crucial when using antisense oligonucleotides for gene-targeting 
experiments. In this dissertation, translation-inhibiting morpholinos directed against the 
members of the zebrafish matrilin family were employed. The amount of matrilin 
protein was therefore evaluated to determine whether the gene of interest has been 
specifically targeted. Indeed, whole mount antibody staining of matrilin-4 knockdown 
embryos at 24 hpf revealed that matrilin-4 was lost from the myosepta (Fig. 3-26), even 
though embryos did not show any apparent abnormality in body shape. The lack of an 
obvious phenotype in the embryos injected with low dose of matrilin-4 morpholino 
could be due to a dose-dependency which will be discussed later in detail. Nevertheless, 
knockdown embryos injected with a high dose of matrilin-4 specific morpholino 
showed a curled body and sometimes truncated body as well as a small head with 
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 poorly developed eyes (Fig. 3-26, 27 and 31). These phenotypes may be due to the lack 
of expression of matrilin-4 in the skeleton, the myosepta and the eyes. In addition, a 
higher mortality was observed for matrilin-4 knockdown embryos as compared to 
controls, which may correlate to its early and wide expression. 
The matrilin-1 knockdown phenotypes perfectly match the expression pattern. In 
addition to in skeletal tissues, zebrafish matrilin-1 is also expressed in the notochord. 
Matrilin-1 knockdown embryos present a curled body and alcian blue staining showed 
an abnormal skeletal phenotype. A retinal expression of matrilin-1 has been reported for 
human embryos (Mundlos and Zabel, 1994). In the matrilin-1 knockdown embryos the 
eyes were poorly developed which may indicate a role of matrilin-1 in zebrafish eye 
development. 
As the antibody against matrilin-1 shows high cross-reactivity to matrilin-3b, it was not 
yet possible to demonstrate the loss of matrilin-1 protein in morpholino injected 
embryos. The cross-reactivity has to be eliminated prior to using this antibody in 
immunostaining. It was excluded that the cross-reactivity is due to the His6 epitope, 
which is included in the recombinant protein to enable affinity purification (results not 
shown). Even though the cross-activity could be reduced by preincubation of matrilin-1 
antibody with matrilin-3b protein, the optimal condition for immunostaining application 
still has to be determined. 
The matrilin-3a knockdown showed serious defects in skeletal development in 
agreement with the restricted expression in cartilage. The embryos display a curled 
body axis and small heads. However, a more detailed analysis has to be performed to 
elucidate the role of matrilin-3a in the skeletal development of zebrafish. 
4.3.2. Dose dependency of morpholino knockdown effects  
It is important that consistent results are obtained when a fixed morpholino dose is 
injected into a group of embryos. The optimal dose varies for each gene specific 
morpholino and must therefore be determined separately. At the time of writing this 
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 dissertation, the optimal doses of morpholinos have not yet determined for each matrilin. 
Nevertheless, it could be shown that skeletal malformations occur in all matrilin 
knockdown embryos at all the doses used and not with control morpholinos at similar 
dosage. Interestingly, the severity of malformations depended on the amount of 
morpholino injected. At low doses, matrilin-1 knockdown embryos show a curled body 
shape and abnormal caudal fin, while at high doses, the body axis no longer develops 
(Fig. 3-28). Similarly, at low doses the expression of matrilin-4 in myoseptum 
disappears even though the embryos do not show any apparent abnormality. However, 
at a higher doses, a curled body shape along with poor eye development could be 
observed paralleling the absence of the expression in myoseptum (Fig. 3-26). The 
coexpression of matrilin-1 and –4 may explain the lack of phenotype in the eyes when 
low doses of matrilin-4 morpholino were injected, while at high dose, the defect in the 
eyes may be too serious to be compensated by matrilin-1. Such dose dependent 
knockdown phenotypes are consistent with observations made for bmp7 and chordin 
(Heasman, 2002; Imai and Talbot, 2001; Nasevicius and Ekker, 2000).  
4.3.3. Strength and limitations of morpholinos 
The morpholinos used in these studies function through an RNase H independent 
mechanism by hindering translational initiation. This approach makes the morpholino 
targeting highly predictable and significantly reduces non-specific effects. In contrast, 
RNAi, which is effective and can give reproducible results in nematode and Drosophila, 
yields highly variable and controversial results in zebrafish (Li et al., 2000; Oates et al., 
2000). Morpholinos have been shown to be very effective in tissue culture and in 
several model organisms. They are completely resistant to nucleases and also to a broad 
range of other degradative factors occurring in biological systems (Hudziak et al., 1996). 
Therefore, the use of morpholinos avoids complications which could rise from toxic 
degradation products and also are effective even in long-term experiments. The efficacy 
is related to the effective concentration of morpholinos in the organism. When 
transcriptional rates are very high, morpholinos may be too dilute to be effective. In a 
cell-free system, it has been shown that morpholinos can achieve a high efficacy at 
concentrations above about 10 nM, and maintain their high sequence specificity up to 
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 10,000 nM, the hightest concentration tested (Summerton and Weller, 1997). However, 
the effective time scheme has not been well studied. It has been reported that 
morpholinos are extremely potent in all cells through the first 50 hours of development 
(Nasevicius and Ekker, 2000). In a receptor protein-tyrosine phosphatase knockdown 
zebrafish, it was shown that the lamination of the retina starts to be restored from 5 dpf 
(van der Sar et al., 2002).  
The temporal expression of zebrafish matrilins was characterized by RT-PCR from 24 to 
72 hpf. Matrilin-1, for example, gives a strong band at 72 hpf. However, in situ 
hybridization of 56 hpf embryos showed staining of matrilin-1 in pectoral fins (B. 
Kobbe, pers. communication). Therefore, it is possible that a weak matrilin-1 expression 
starts earlier than 72 hpf. In contrast matrilin-4 is strongly expressed already at 24 hpf. 
The early expression of matrilins, at stages when only a limited number of cells are 
present, enhances the chance for a morpholino to be effective when delivered already at 
the 1-cell stage. The early expression of matrilins enables the morpholinos to bind to all 
mRNAs and results in complete absence of protein. In addition, the turnover rate of 
extracellular matrix proteins is relatively slow and it is possible that matrilins cannot be 
restored later on. Therefore, it would be interesting to monitor also the later 
development and adult fish. However, the embryos with serious malformations often die 
before 5 dpf, indicating that matrilins play a vital and fundamental role during 
embryonic development of zebrafish.  
4.3.4. Proper controls in morpholino experiments 
The specificity is always the major concern in such gene-targeting experiments. In most 
publications which make use of the morpholino approach, critical controls and 
statistical data on phenotype frequency and survival rate are missing.  
Mistargeting was defined as the fraction of unexpected phenotypes due to inhibition of a 
second gene and results in embryos with a composite phenotype (Ekker and Larson, 
2001) and was shown to occur in 18% of fish even under rather stringent morpholino 
conditions (Ekker, 2000). An example is represented by the bozozok/dharma 
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 morpholino, in which embryos additionally display a unwanted neural degeneration 
phenotype resulting in a high mortality (Nasevicius and Ekker, 2000). Such limitations 
lead to difficulties in phenotype interpretation and proper controls hence become critical. 
The probability of erroneous interpretation can be decreased by targeting one gene with 
two morpholinos of independent sequence and comparison of phenotypes from two 
independent knockdown embryos. Rescue experiments may also be performed by 
injecting mRNA of the gene of interest to confirm the specificity of morpholino (Amali 
et al., 2004; Yan et al., 2005). It must still be kept in mind that the toxicity, diffusion and 
penetration of mRNA and morpholino differ.  
Another type of control frequently used is to inject either a nonsense or a mismatched 
morpholino. Of course, antibody analysis is a direct and powerful way to demonstrate 
whether the gene of interest has been successfully targeted. However, those controls still 
do not show whether a second gene is simultaneously targeted.  
Often not all embryos present phenotypes and the phenotypes vary in severity. The 
differences in the degree of depletion may be due to the amount of protein present at the 
time of morpholino injection, the rate of diffusion, the localization of targeted mRNA 
and the rate of new transcription (Heasman, 2002). Therefore, calculation of phenotype 
frequency is important to correctly interpret the knockdown effect.  
4.4. The difference in phenotype between knockout 
mice and knockdown zebrafish 
Even though slight molecular changes are present in matrilin-1/-3 double knockout mice, 
single knockout matrilin-1, -2 and –3 mice have no obvious phenotype, possibly due to 
a redundancy in matrilin function in mice. The presence of highly conserved zebrafish 
orthologues, showing similar spatial and temporal expression, points to an important 
biological function of this gene family. In contrast to in mice, knockdown of each of the 
matrilins in zebrafish alone causes marked skeletal malformations. The reproducible 
results and significant difference of phenotype frequency between embryos injected 
with nonsense morpholinos and embryos injected with matrilin-1 morpholinos 
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 strongly indicate that the skeletal abnormalities in the knockdown embryos are caused 
by matrilin depletion.  
The contrary results between two different model organisms may be due to the degree 
of complexity in protein interaction and regulation. Even though the information on 
matrilin interactions is increasing, it is still not clear to what extent this role is static or 
dynamic in vivo. Extracellular matrix proteins and their interactions are even less 
characterized in zebrafish. It is possible that zebrafish express fewer extracellular matrix 
proteins and/or that the interactions between them are less complex, resulting in more 
pronounced phenotypes in this model organism.  
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 5. Perspectives                          
Studies in zebrafish will provide a better insight into matrilin function. Morpholinos, 
potent antisense oligonucleotides, provide a fast, specific and less elaborate means to 
screen multiple genes for function. Much time and effort can be saved by investigating 
the function of a novel gene first in zebrafish by morpholino knockdown approach 
before going on to a higher model organism.  
Beyond a more detailed analysis of the single knockdowns, double or triple 
knockdowns of zebrafish matrilins will be conducted to show a potential cooperative 
effect on the skeletal development. This will provide an indication of which of the 
possible double/triple mouse matrilin knockout should be performed first. 
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 Abbreviations                          
BHMED Bilateral hereditary micro-epiphyseal dysplasia  
BSA Bovine serum albumin  
COMP  Cartilage oligomeric matrix protein 
DAB Diaminobenzidine  
DDR Discoidin domain receptor 
DMB Dimethylmethylene blue  
dsRNA Double-strand RNA 
EBNA  Epstein–Barr nuclear antigen 
ECM Extracellular matrix  
EDTA Ethylenediaminetetraacetic acid 
EGF   Epidermal growth factor 
EtOH Ethanol 
GAG   Glycosaminoglycan 
GAPDH  Glyseraldehyde-3-phosphate dehydrogenase 
HE  Hematoxylin-eosin  
HEK-293 Human embryonic kidney cell clone 293 
hpf Hour post fertilization 
ihh Indian hedgehog  
kDa Kilodalton 
LRR Leucine-rich repeat 
MALDI-TOF Matrix-assisted laser desorption ionization- time of flight 
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 MED  Multiple epiphyseal dysplasia 
MIDAS Metal ion dependent adhesion site 
mRNA  Messenger ribonucleic acid 
NMR Nuclear magnetic resonance 
PBS Phosphate buffered salts 
p.c.   Post coitus 
PFA Paraformaldehyde 
pNPP 4-nitrophenylphosphate disodium salt hexahydrate 
Ppr Parathyroid hormone/ parathyroid hormone-related peptide 
receptor  
PSACH Pseudoachondroplasia  
RISC RNA-induced silencing complex  
RNAi RNA interference 
RT-PCR  Reverse-transcriptase polymerase chain reaction 
siRNA Small-interference RNA 
SDS-PAGE   Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SEMD Spondylo-epi-metaphyseal dysplasia  
SLRP Small leucine-rich proteoglycan 
TRAP Tartrate-resistant alkaline phosphatase  
VWA  Von Willebrand factor A 
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